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ABSTRACT 
 
Liver function is a dominant factor in the survival of patients with hepatocellular carcinoma 
(HCC). Measures of regional and global liver function are critical in guiding treatments for 
intrahepatic cancers. Regional and global liver function assessments important for defining the 
magnitude and spatial distribution of radiation dose to preserve functional liver parenchyma and 
reduce incidence of hepatotoxicity from radiation therapy (RT) for intrahepatic cancer treatment. 
This individualized liver function-guided RT strategy is critical for patients with heterogeneous 
and poor liver function, often observed in cirrhotic patients treated for HCC.  Dynamic 
gadoxetic-acid enhanced (DGAE) magnetic resonance imaging (MRI) allows investigation of 
liver function through observation of the uptake of contrast agent into the hepatocytes. 
 
This work seeks to determine if gadoxetic uptake rate can be used as a reliable measure of liver 
function, and to develop robust methods for uptake estimation with an interest in the therapeutic 
application of this knowledge in the case of intrahepatic cancers. Since voxel-by voxel fitting of 
the preexisting nonlinear dual-input two-compartment model is highly susceptible to over fitting, 
and highly dependent on data that is both temporally very well characterized and low in noise, 
this work proposes and validates a new model for quantifying the voxel-wise uptake rate of 
gadoxetic acid as a measure of regional liver function. A linearized single-input two-
compartment (LSITC) model is a linearization of the pre-existing dual-input model but is 
designed to perform uptake quantification in a more robust, computationally simpler, and much 
faster manner. The method is validated against the preexisting dual-input model for both real and 
simulated data.  Simulations are used to investigate the effects of noise as well as issues related 
to the sampling of the arterial peak in the characteristic input functions of DGAE MRI. 
 
Further validation explores the relationship between gadoxetic acid uptake rate and two well 
established global measures of liver function, namely: Indocyanine Green retention (ICGR) and 
Albumin-Bilirubin (ALBI) score. This work also establishes the relationships between these 
 xi 
scores and imaging derived measures of whole liver function using uptake rate. Additionally, the 
same comparisons are performed for portal venous perfusion, a pharmacokinetic parameter that 
has been observed to correlate with function in patients with relatively good liver function, and 
has been used as a guide for individualized liver function-guided RT. For the patients assessed, 
gadoxetic acid uptake rate performs significantly better as a predictor of whole liver function 
than portal venous perfusion. 
 
This work also investigates the possible gains that could be introduced through use of gadoxetic 
uptake rate maps in the creation of function-guided RT plans. To this end, plans were created 
using both perfusion and uptake, and both were compared to plans that did not use functional 
guidance. While the plans were generally broadly similar, significant differences were observed 
in patients with severely compromised uptake that did not correspond with compromised 
perfusion. 
 
This dissertation also deals with the problem of quantifying uptake rate in suboptimal very 
temporally sparse or short DGAE MRI acquisitions. In addition to testing the limits of the LSITC 
model for these limited datasets (both realistic and extreme), a neural network-based approach to 
quantification of uptake rate is developed, allowing for increased robustness over current models.
 1 
CHAPTER 1  
Introduction 
 
In the treatment of liver cancer, the competing goals of controlling tumor growth and 
maintaining liver function must be balanced against one another. The fundamental goal is to 
maintain sufficient liver function to prevent short term liver failure, while sufficiently controlling 
tumor growth to prevent further growth of the cancer. This is of particular concern in radiation 
therapy, where the dose targeted for the cancer will inevitably cause some, albeit reduced, 
damage to the tissues near the lesion. It is thus essential to ensure, prior to treatment, that the 
retained liver function after treatment or retained “functional volume” is sufficient1. 
 
Metastatic cancers in the liver are most likely to leave overall liver function outside the tumor 
volumes relatively unaffected. In these cases, it is logical to assume that overall functional loss 
will be roughly proportional to the non-tumor area damaged by therapy. The radiation induced 
damage on normal tissue can be modeled based on the observed response in a sample 
population1–3. This damage can be assessed using a measure of whole liver function, e.g. 
indocyanine green (ICG) retention1,4 or Albumin-bilirubin (ALBI) score5, to ensure that the 
radiation dose does not exceed the threshold to cause liver failure. 
 
However, some pathologies, such as cirrhosis, compromise function throughout the liver4,6. 
Additionally, this compromise is often inhomogeneous, and not limited to identifiable lesions. 
Cirrhosis is often a comorbidity with Hepatocellular Carcinoma (HCC), meaning treatment of 
HCC tumors must consider this inhomogeneous functional distribution. It is in cases like this that 
measures of regional liver function are particularly necessary7,8. Without regional measures the 
uncertainty in retained function is greatly raised, making it more difficult to effectively control 
tumor growth without increasing the likelihood of liver failure to an unacceptable degree. Thus, 
while global measures do allow for clinicians to monitor treatment and pause or modify 
treatment plans to avoid radiation induced liver disease (RILD) and liver failure, regional 
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measures allow a more granular understanding of functional distribution, enabling radiation 
targeting such that the likelihood of both RILD and of continued tumor growth are 
simultaneously lowered.  
 
Various methods currently exist for determining regional liver function. Positron emission 
tomography (PET) and single positron emission computed tomography (SPECT) with 
radioactive hepatobiliary tracers, have been developed for direct measurement of regional liver 
function7,9,10. MRI-based methods benefit from superior spatial and temporal resolutions and soft 
tissue contrast. Similar advantages have motivated MRI guided radiation therapy11,12.  Dynamic 
contrast enhanced (DCE) MRI with the correct contrast allows for physiological investigation of 
liver function. Vascular contrast agents, such as Gadobenic acid have enabled interrogation of 
portal venous perfusion through dynamic Gadobenic acid enhanced MRI scans of the liver13–15. 
Analysis of the resulting imaging allows for determination of the perfusion parameters 
throughout the liver. Portal vein perfusion in particular has been implemented for this purpose, 
operating on the assumption that poor liver health is correlated with compromised perfusion in 
that region. Portal venous perfusion has been found to be significantly correlated with overall 
function evaluated via indocyanine green (ICG) clearance or retention13,16,17. However, since this 
is an indirect surrogate for function there is reason to doubt this is an accurate measure when 
function is more heterogeneous as in HCC. 
 
Though its kinetics are more complex, a hepatobiliary contrast, such as gadoxetic acid more 
directly applicable to the assessment of function. Marketed in the United States as Eovist, and as 
Primovist in Europe, gadoxetic acid is a hepatobiliary contrast that allows direct assessment of 
liver function through contrast uptake in liver parenchyma18.  Hepatobiliary contrasts are 
distinguished from vascular agents in that they are taken up into the liver cells, allowing more 
direct interrogation of liver function. Over the course of a gadoxetic acid enhanced (DGAE) 
MRI, the gadoxetic acid uptake rate in a given region is a meaningful quantifier of functioning 
hepatocytes in that region. Since hepatocytes are the drivers of liver function, this is very direct 
method of quantifying liver function14,19–21. 
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While the hepatobiliary property of gadoxetic acid is of great interest for the assessment of liver 
function, currently gadoxetic acid is only indicated for use in assessing intrahepatic lesions 
clinically18. Correspondingly, most current gadoxetic acid scans are conducted for diagnostic 
purposes, allowing the localization, identification, and characterization of tumors within the 
liver. The vascular and hepatobiliary properties of the contrast allow for discrimination of tumor 
properties from a few MRI volumes acquired at a few key times. Recommended acquisitions 
generally include 6 image volumes over approximately 20 min. The first four phases are meant 
to capture the pre-enhancement phase, arterial phase, portal venous phase, and “mixing phase” 
respectively. The remaining volumes attempt to characterize the hepatobiliary phase, where 
uptake is a predominant feature. While only indicated for lesion characterization, the same 
properties that motivate this use case also open the door for interrogation of voxelwise liver 
function, rather than mere tumor identification18.  
 
The kinetics of gadoxetic acid can be described using a dual-input two-compartment (DITC) 
model of liver function, where the dual inputs are due to the unique physiology of the liver’s 
vasculature20. In addition to an arterial blood supply, the liver has a portal venous blood supply, 
responsible for carrying nutrients from the digestive system to the liver.  Blood from both the 
arteries and the portal vein leave the liver via the hepatic vein. The two compartments represent 
the relevant intra and extracellular spaces. With the introduction of gadoxetic acid, the relative 
signal strength at a given location can be used to estimate the concentration of contrast at that 
location.  Using the concentration over time in the arterial and portal venous input, along with 
the concentration at an ROI, the contrast kinetics can be fit and quantified using the DITC model. 
The DITC model of gadoxetic acid kinetics is non-linear, and depends on simultaneous fitting of 
6 parameters, a problem with significant computational complexity and challenges for robust 
fitting20.  Such a method completely rules out using the relatively common low temporal 
resolution (LTR) scans, as the data points typically required leave the problem very 
underdetermined. An accurate fit using the DITC model requires well temporally characterized 
data, with imaging volumes acquired every 5 to 10 seconds. This fitting is also sensitive to noise, 
an issue that is compounded by the short acquisition time allowed for each volume.22 
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In addition to the direct benefits of an accurate measure of liver function in tailoring radiation 
therapy plans, a sufficiently accurate measure of regional liver function would also allow for 
replacement of tests used to quantify whole liver function, which are important for evaluating 
individual patient risk of RILD. This would then allow for a single acquisition to characterize the 
tumors, map liver regional liver function, and evaluate the whole liver function. 
 
In any imaging examination, the time taken for the patient and the clinicians should be 
minimized for overall convenience and economic viability, as well as increased likelihood of 
patient capacity to complete the scan with minimal discomfort or motion. Machine learning 
approaches such as neural networks have introduced powerful means for extracting useful 
information, regression, classification, and decision making from restricted data sets, using 
learned features that do not have to be identified and crafted by human agents. In the best cases 
neural network based approaches can perform as well as the best crafted models with less 
information. If neural network based methods could give comparable results to 20 minutes of 
temporally well characterized data assessed via preexisting model based methods, using smaller, 
more restricted datasets, it would be extremely valuable. Additionally, if neural network based 
approaches could derive reliable uptake rate maps using only LTR data, the generalizability of 
gadoxetic acid uptake rate would be substantially improved with minimal workflow changes 
required. 
 
This work seeks to determine if gadoxetic uptake rate can be used as a reliable measure of liver 
function, and to develop robust methods for uptake estimation with an interest in the therapeutic 
application of this knowledge in the case of intrahepatic cancers.  
 
Chapter 2 introduces a model for quantifying the voxel wise uptake rate of gadoxetic acid as a 
measure of regional liver function. This model is derived from the pre-existing dual-input two-
compartment model but is designed to perform uptake quantification in a computationally 
simpler, more robust, and much faster manner. The method is compared against the dual-input 
two-compartment model for real and simulated data. Simulations are used to investigate the 
effects of noise as well as issues related to the sampling of the arterial peak in the characteristic 
input functions of dynamic gadoxetic acid enhanced MRI. This chapter also Goes into more 
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depth on the specifics of the DITC model, and the relative advantages of the gadoxetic acid 
uptake rate used here, as compared to other measures that depend on gadoxetic uptake. 
 
Chapter 3 goes into greater depth in validating this measure of liver function against well 
regarded measures of global liver function (ICG and ALBI), and compares uptake to a promising 
pre-existing surrogate for liver function: portal venous perfusion. The comparisons with global 
functional measures also provide calibrations for calculating equivalent ICG and ALBI scores 
from DGAE imaging. This enables adherence to guidelines defined using ICG or ALBI but 
informed only by the imaging measure. This chapter also contains comparisons to contemporary 
work related to the quantification of regional uptake rate of Gadoxetic acid. 
 
Chapter 4 evaluates the relative gains in using uptake rate instead of perfusion in functional 
avoidance RT planning. This is performed by comparing RT plans created using each method for 
a small set of patients. Evaluations determine the differences between the dose distributions in 
each plan, with a focus on reduced dose to highly functioning regions. 
 
Chapter 5 tests the limits of the model for suboptimal data, in terms of both the temporal length 
of the acquisition and the extreme under sampling of LTR data. Furthermore, this chapter 
examines machine learning techniques to improve performance in these extreme cases. These 
approaches focus on LTR style undersampling, using a simple neural network to estimate actual 
uptake from this restricted dataset. Training is tested using both real and simulated data. 
Additionally, data augmentation is investigated via the generation of random realistic arterial 
input functions using a generative adversarial neural network.  
 
Table 1.1 Table of abbreviations appearing in text with corresponding definitions 
Abbreviation Definition 
AIF Arterial Input Function 
ALBI Albumin-Bilirubin 
CNN Convolutional Neural Network 
CP Child-Pugh 
DCE Dynamic Contrast Enhanced 
DGAE Dynamic Gadoxetic Acid Enhanced 
DITC Dual-Input, Two-Compartment 
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EMD Earth Mover’s Distance 
GAN Generative Adversarial Network 
GTV Gross Tumor Volume 
HCC Hepatocellular MRI 
Hct Hematocrit 
HEF Hepatic Extraction Fraction 
HTR High Temporal Resolution 
ICG Indocyanine Green 
ICGR Indocyanine Green Retention 
ICGR15 ICG retention at 15 minutes 
LLS Linear Least Squares 
LSITC Linearized Single-Input, Two-Compartment 
LTR Low Temporal Resolution 
LV/SLV Liver to spleen ratio 
MRI Magnetic Resonance Imaging 
MSE Mean Squared Error 
NLLS Non-Linear Least Squares 
NN Neural Network 
NRMSE Normalized Root Mean Squared Error 
NTCP Normal Tissue Complication Probability 
OAR Organ At Risk 
PK Pharmacokinetic 
PVIF Portal Venous Input Function 
RE Relative Enhancment 
RILD Radiation Induced Liver Disease 
ROI Region of Interest 
RT Radiation Therapy 
SBRT Stereotactic Body Radiation Therapy 
SD Standard Deviation 
SNR Signal to Noise Ratio 
WAPE Weighted Absolute Percent Error 
WMAPE Weighted Mean Absolute Percent Error 
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CHAPTER 2  
A Linearized Two-Compartment Model of Gadoxetic-Acid Kinetics in the Liver 
 
This chapter is substantially equivalent to work the author has already published in NMR in 
Biomedicine22. 
 
2.1 Introduction 
The hepatobiliary properteris of gadoxetic acid make it an attractive contrast for assessing 
regional liver function. Using this agent, hepatic extraction fraction (HEF) can be estimated to 
assess liver function. While HEF is directly related to uptake rate, it cannot isolate uptake rate 
from the effects of plasma flow14,23. Semi-quantitative measures such as relative enhancement 
(RE) and enhancement relative to spleen similarly cannot differentiate between uptake rate and 
plasma flow, while additionally either ignoring fluid enhancement or assuming its uniform 
conformity to fluid enhancement in the spleen14. A dual-input two-compartment model of liver 
function can be used to directly estimate the uptake rate, but the model requires high temporal 
resolution images to adequately characterize the concentration curves used as inputs, can have as 
many as 6 unknown parameters, and may be susceptible to over fitting variance in the data 20. 
This chapter develops and applies a linear model based on the dual-input two compartment 
model of liver function. Ideally, this model can be used to estimate both flow dependent and 
independent measures of liver function with decreased computational complexity and 
susceptibility to variance as compared to the dual-input two-compartment model. To this end we 
compare the results of the developed model to the dual-input two-compartment model as applied 
to high-temporal resolution gadoxetic-acid enhanced MRI data, and to ICG retention in livers 
with corresponding clinical temporally-sparse MRI data. Through simulations we also assess the 
impact of failure to capture the peak of the arterial input function on the estimate of uptake. This 
allows us to confirm the correspondence of our approach to the two-compartment model for liver 
function, and to an independent and reliable measure of whole liver function found in the 
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extraction by the liver of ICG24, while confirming the applicability to low temporal resolution 
clinical datasets. 
2.2 Methods and Materials 
2.2.1 Dual-Input Two-Compartment Model 
2.2.1.1 Model Description. The dual-input two-compartment (DITC) pharmacokinetic (PK) 
model of gadoxetic acid in the liver20 is illustrated in figure 2.1. This model describes the 
hemodynamics of gadoxetic acid (hepatic arterial and portal venous perfusion), and contrast 
uptake of hepatocytes.  In this model, after injection of a bolus of gadoxetic acid, the contrast 
circulates in the blood by flowing in from both hepatic artery and portal vein into the sinusoids, 
distributing in the space of Disse and flowing out through the central and hepatic veins. This 
assumes fast exchange between the sinusoids and the space of Disse. Meanwhile, hepatocytes 
take up the contrast through the sinusoid membrane.  The contrast uptake of hepatocytes is 
assumed to be unilateral, by omitting the minor efflux of the contrast back to sinusoids in the 
initial retention period25. This model also omits the slow and delayed excretion process. 
 
 
Figure 2.1. A dual-input two-compartment pharmacokinetic model of gadoxetic acid in the liver. 
If we consider a voxel or a volume of interest with a total volume of Vt , the total amount of 
contrast in the voxel is a sum of the amounts of contrast in the extracellular and intracellular 
spaces, and can be described by the following equations: 
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VtCt(t)
⏞    
Contrast in Tissue
= VdisCdis(t)
⏞    
Extracellular Contrast
+ k1 ∫ VdisCdis(τ)dτ
t
0
⏞          
Intracellular Contrast
    (2.1) 
VdisCdis(t)=Vdis ∫ (kaCa(τ-τa)+kpvCpv(τ-τpv)) e
-(t-τ)(k2+k1)dτ
t
0
   (2.2) 
where Vdis is the distribution volume of blood; Ct, Cdis , Ca, and Cpv are contrast concentrations as 
a function of time in the respective total, distribution, arterial, and portal vein volumes; τa and τpv 
describe respective arrival time delays of the arterial and portal vein input functions at each voxel; 
ka and kpv describe the normalized arterial and portal venous flow rates, and  k2 is the normalized 
flow rate leaving the volume of interest through the central vein. k1 is the normalized rate of uptake 
of contrast to the intracellular space. The distribution volume includes the Space of Disse and 
sinusoids.  We also define a fractional distribution volume of vdis= 
Vdis
Vt
 .  The derivation and a 
detailed description of equations are given in appendix A. 
 
Ct, Ca, and Cpv are measurable from the intensity of dynamic contrast enhanced MRI at regions 
or voxels of hepatic tissue, artery, and portal vein respectively. As a result, equations (2.1) and 
(2.2) have 6 unknown variables (ka, kpv, τa, τpv, k1 and vdis) to be determined.  
    
2.2.1.2 Optimization. To determine the 6 unknown variables in equations (2.1) and (2.2), the cost 
function 
∑ [Ct(iT)-?̂?t(iT)]
2Nt-1
i=0      (2.3) 
is optimized. Here 𝐶?̂? is the estimate of Ct given by the model in equation (2.1) with guessed 
values of ka, kpv, τa, τpv, k1 and vdis during the optimization process. T is the temporal interval 
between time points and Nt is the total number of time points in the DCE curves.  This work used 
the Nelder Mead Simplex algorithm to perform the optimization. 
2.2.2  Linear single-input two-compartment model 
2.2.2.1 Rationale. Since fitting the DITC PK model requires the optimization of 6 parameters, it 
is susceptible to overfitting of variations due to noise, and also is time consuming when fitting a 
long dynamic series of data in the whole liver.  Estimating k1 (the contrast uptake rate of 
hepatocytes) requires a long time period of observation of the contrast accumulation in 
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hepatocytes.  The hemodynamic changes after the initial transient time following the contrast 
bolus injection become slow.  This offers an opportunity to solve the problem in a different 
manner, producing a computationally simpler problem and, ideally, reducing susceptibility to 
variation. Assumptions used in the derivation and formula are described in the following 
subsections 
 
2.2.2.2 Assumptions & Formulation. The change in the total amount of contrast in the 
distribution volume in a voxel is: 
 
Vdis
dCdis(t)
dt
 = 𝑉𝑑𝑖𝑠[kaCa(t-τa)+kpvCpv(t-τpv)]-𝑉𝑑𝑖𝑠(k2+k1)Cdis(t)   (2.4) 
 
which is equation (2.2) in the derivative form.  Given the long acquisition period for observation 
of gadoxetic-acid uptake in hepatocytes, after a few circulations of the contrast bolus in the blood 
(t > tp), the contrast concentration in the portal vein blood is eventually equal to that in the 
arterial blood, 𝐶𝑎(𝑡) = 𝐶𝑝𝑣(𝑡).  Under this condition, equation (2.4) can be re-written as: 
 
𝑉𝑑𝑖𝑠
𝑑𝐶𝑑𝑖𝑠(𝑡)
𝑑𝑡
 = 𝑉𝑑𝑖𝑠 𝑘t𝐶𝑎(𝑡) − (𝑘1 + 𝑘2)𝑉𝑑𝑖𝑠𝐶𝑑𝑖𝑠(𝑡 )  when t>𝑡𝑝   (2.5) 
where kt = (ka+kpv) = (1-Hct)k2, the normalized total blood flow rate in Vt, and Hct is hematocrit. 
Equation (2.5) can be re-arranged as:  
𝐶𝑑𝑖𝑠(𝑡) =
𝑘𝑡
𝑘1+𝑘2
𝐶𝑎(t) -
1
𝑘1+𝑘2
𝑑𝐶𝑑𝑖𝑠(𝑡)
𝑑𝑡
   when t>𝑡𝑝    (2.6) 
Substituting Cdis in equation (2.6) into the second term in equation (2.6), equation (2.6) can be 
further re-written as: 
𝐶𝑑𝑖𝑠(𝑡) =
𝑘𝑡
𝑘1+𝑘2
𝐶𝑎(t)  - 
𝑘𝑡
(𝑘1+𝑘2)2
𝑑𝐶𝑎(𝑡)
𝑑𝑡
 + O(
𝑑2𝐶a(𝑡)
𝑑𝑡2
 ) + …  when t>𝑡𝑝      (2.7) 
where the first term depends upon Ca, the second term depends upon the first derivative of Ca, 
the third term depends upon the second derivative of Ca, and so on.  If the second derivative of 
Ca is small enough to be neglected, substituting equation (2.7) into equation (2.1) and re-
arranging the terms, we have: 
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(1 − 𝐻𝑐𝑡)𝐶𝑡(𝑡) = 𝑣𝑑𝑖𝑠
𝑘2
𝑘1+𝑘2
{(1 −
𝑘1
𝑘1+𝑘2
)𝐶𝑎(𝑡) + 𝑘1 ∫ 𝐶𝑎(𝜏)
𝑡
0
𝑑𝜏 −
1
𝑘1+𝑘2
𝑑𝐶𝑎(𝑡)
𝑑𝑡
}     (2.8) 
Equation (2.8) can be considered as the linear problem 𝑦 = ax1 +bx2 +cx3, where 𝑦 = (1 −
𝐻𝑐𝑡)𝐶𝑡(𝑡), and ?⃗? = (𝑥1, 𝑥2, 𝑥3) = (𝐶𝑎(𝑡), ∫ 𝐶𝑎(𝜏)
𝑡
0
𝑑𝜏,
𝑑𝐶𝑎(𝑡)
𝑑𝑡
). A linear least squares (LLS) fit 
can estimate coefficients of a, b and c. k1, k2 and vdis can be solved from the coefficients (see 
appendix B).   
If the second term (related to the first derivative of Ca) in equation (2.7) can be neglected, we 
have: 
(1 − 𝐻𝑐𝑡)𝐶𝑡(𝑡) = 𝑣𝑑𝑖𝑠
𝑘2
𝑘1+𝑘2
{𝐶𝑎(𝑡) + 𝑘1 ∫ 𝐶𝑎(𝜏)
𝑡
0
𝑑𝜏}     (2.9)                     
Again, equation (2.9) is a linear problem, y = ax1+bx2, where 𝑦 = (1 − 𝐻𝑐𝑡)𝐶𝑡(𝑡), and ?⃗? =
(𝑥1, 𝑥2) = (𝐶𝑎(𝑡), ∫ 𝐶𝑎(𝜏)
𝑡
0
𝑑𝜏), which can be solved by LLS fitting. In this case, 𝑘1 =
𝑏
𝑎
 . Note 
that there is no assumption made relating to k1 and k2; and but k2 and vdis cannot be solved.  Also, 
equation (2.9) can be re-arranged to be: 
 
(1−𝐻𝑐𝑡)𝐶𝑡(𝑡)
𝐶𝑎(𝑡)
⏞      
𝑦
= 𝑣𝑑𝑖𝑠𝑘1
𝑘2
𝑘1+𝑘2
⏞      
𝑠𝑙𝑜𝑝𝑒
∫ 𝐶𝑎(𝜏)𝑑𝜏 
𝑡
0
𝐶𝑎(𝑡)
⏞    
𝑥
+ 𝑣𝑑𝑖𝑠
𝑘2
𝑘1+𝑘2
⏞    
𝑖𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡
                                        (2.10) 
which is a form of the Patlak analysis26. Note that k1 can be calculated by slope/intercept, and is 
not affected by the relationship between k1 and k2, which is different from the Patlak analysis.  
The intercept in the Patlak analysis is called veff and is usually greater than the true blood 
distribution volume.  The intercept in our case, 𝑣𝑑𝑖𝑠
𝑘2
𝑘1+𝑘2
 , is smaller than vdis.  However, if we 
assumed that k2>>k1, vdis can be estimated by the intercept. Note that we only used the 
assumptions: 𝐶𝑎(𝑡)= 𝐶𝑝𝑣(𝑡) and that there is slow contrast change in the blood after t > tp, to 
derive these equations. We will call it the linearized single-input two-compartment (LSITC) 
model hereafter. 
2.2.2.3 Optimization.  Optimization of equation (2.10) involves first computing the vector x and 
the set of vectors y (one for each voxel).  Additionally, tp (or xp corresponding to tp) needs to be 
determined.  Based on the assumptions of the model, x and y will be linearly related after xp, 
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suggesting a linearity test is needed. If it is assumed that xp is relatively consistent throughout the 
liver a single test can be performed, reducing noise effects and saving computation time. 
 
To obtain xp, the vectors y are averaged over all voxels within the liver to form a single vector. 
The two singular values of the centered data matrix [x y] after the tested xp are acquired by the 
singular value decomposition.  The tested xp is varied within a time interval between the arterial 
peak and 2 min before the last data point. The ratio of the first singular value to the second is 
calculated to determine the linearity of the relationship.  xp is then chosen to maximize this ratio. 
Figure 2.2 illustrates the behavior of the y vector before and after xp in a region of interest. 
However, in cases with sparse temporal sampling the process can be simplified by setting tp 
based on the DCE data with high temporal sampling.  
 
Figure 2.2. An example of the relationship between the vectors y and x in equation (2.10) from a volume of interest in the liver. 
Note that the linear assumptions of the model only bear out after the transition point xp. 
After selection of xp total least squares regression is performed for each voxel using the data after 
xp to minimize the impact of errors in both x and y. The slope of the resulting fit is divided by the 
intercept to determine the value of k1 in the voxel. In cases where the intercept is less than 0.02, 
k1 is set to zero to prevent values from blowing up. This is also justified in that a low intercept, 
corresponding to a sufficiently low vdis will effectively preclude meaningful levels of uptake in 
the voxel. 
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2.2.3  Evaluation 
This chapter evaluates the performance of the LSITC model, with reference to the results of 6 
parameter optimization of the established DITC model, simulated data based on the DITC 
model, global liver function assessment through ICG retention in the plasma, and a comparison 
to literature values. 
 
2.2.3.1 Data Acquisition. In order to compare the results of the proposed LSITC model with the 
DITC model, 3D volumetric DCE MRI of the liver were acquired during the intravenous 
injection of a single standard dose of gadoxetic acid using a Golden-Angle Radial sampling 
VIBE sequence on a 3T scanner (Skyra, Siemens Healthineer) in a prospective protocol 
approved by University of Michigan Institutional Review Board.  A total of 14 exams from 13 
patients with intrahepatic cancers prior to radiation therapy were acquired during free breathing. 
Demographic, pathological, and clinical Child Pugh scores of this group of patients (called 
Group 1) are provided in Table 2.1. Note that 54% of the patients had Child Pugh scores of 5, 
indicating good liver function. In this group of the patients, 3D DCE images were acquired with 
temporal resolutions of 3.5 to 10 seconds and total acquisition times of 4 to 24 minutes, and 
covered the whole liver with 64 to 72 slices with slice thicknesses of 2.6 to 4.5 mm and in-plane 
resolution of 2.1×2.1 mm to 2.4×2.4 mm (192×192 pixels). These scans will be referred to as 
high temporal resolution (HTR) scans. The high temporal resolution scans could be fitted to both 
the DITC model and the LSITC model, allowing comparison of the results obtained from the two 
methods.  
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Table 2.1 The demographic, pathological, and clinical Child Pugh scores for the patient groups used. 
Characteristic 
HTR 
n=13 
LTR 
n=19 
Total 
n=32 
Median Age (range) 60.7 (56.5 - 72.0) 61.1 (52.7 - 78.9) 61.0 (52.7 - 78.9) 
Gender    
     Male 10 (77%) 14 24 
     Female 3 (23%) 5 8 
Cirrhosis    
     Positive  8 (62%) 16* 24 
     Negative  5 (38%) 2* 7 
Histology    
     Hepatocellular carcinoma 9 (69%) 18* 27 
     Adenocarcinoma 2 (15%) 0 2 
     Intrahepatic 
cholangiocarcinoma 
1 (8%) 0 1 
     Solitary fibrous tissue 1 (8%) 0 1 
Baseline Child Pugh     
     5 7 (54%) 5 (28%) 12 (40%) 
     6 4 (31%) 7 (39%) 11 (37%) 
     7 0 (0%) 5 (28%) 5 (17%) 
     8 1 (8%) 1 (6%) 1 (3%) 
     9 1 (8%) 0 (0%) 1 (3%) 
 
In addition, the proposed LSITC model was applied to clinical multi-phase MRI with gadoxetic 
acid in 19 patients, which was approved by a retrospective protocol of University of Michigan 
Cancer Center.  Demographic, pathological, and clinical Child Pugh scores of this second group 
of patients are provided in Table 2.1. Pre- and post-RT scans were acquired from 19 patients, for 
a total of 40 scans. Each patient had been diagnosed with HCC. The scans were comprised of 3D 
volumetric multi-phase MRI of the liver during the intravenous injection of a single standard 
dose of gadoxetic acid on either a 1.5 T GE or a 1.5T Philips scanner.  Each exam consisted of a 
pre-contrast volume, three-phase (arterial and portal vein phases) volumes that were each spaced 
approximately 20 seconds apart, and hepatobiliary phase volumes at approximately 10 and 20 
minutes post contrast, for a total of 6 time points. Each acquisition was obtained during a breath 
hold.  3D MRI had 88 to 124 slices per volume with 256×256 pixels to 512×512 pixels in the 
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plane. The pixel size varied from 0.7×0.7 mm to 1.4×1.4 mm within each slice, with the slice 
thickness consistently 2 mm.  These scans will be referred to as low temporal resolution (LTR) 
scans.  However, due to changes in flip angle between phases in the scan (particularly in the late 
phases) and image quality issues, the set of usable scans was only 27 of the original 40. ICG 
retention exams were carried out near the time of the scan for 20 of the 27 scans, without RT or 
any other treatment having taken place in the meantime. The ICG retention score as a 
quantitative overall liver function assessment was measured as the percentage of the original 
ICG dose remaining 15 minutes after injection, as described previously24, with higher plasma 
retention signifying poorer liver function. The patients in this second group had a median 
baseline ICG retention of 37.2%, with minimum and maximum retention scores of 9.8% and 
50.2%.   
2.2.3.2 Image pre-processing.  For the clinical LTR multi-phase images, interpolation was 
carried out on the image volumes that had different spatial resolutions between the volumes. All 
3D multi-phase LTR MRI volumes in an exam were co-registered using a robust, over-
determined image registration method27.  For all volumes the aorta was contoured from the aortic 
split to the liver up 3 cm. The 100 voxels within this region that had the highest contrast just 
before the arterial concentration peak were averaged to form the arterial input function (AIF). 
For the HTR DCE data, the portal vein was also contoured and selected by the same process to 
obtain the portal vein input function (PVIF). In both cases relative enhancement was used to 
create the input functions: 
C(iT) ∝ 
SIi
SIprecontrast
-1     (2.11) 
where C(iT) describes the relevant concentration at time point i, given a sampling interval of T, 
and SIi and SIprecontrast are the average signal intensities in the given region of interest at time 
point i, and prior to contrast enhancement respectively. The same calculation was performed for 
each voxel in the liver.  
2.2.3.3 Evaluation metrics. k1 maps were obtained from the HTR DCE series using both the 
established DITC model and the proposed LSITC model. The k1 maps obtained from the DITC 
approach were used as a reference standard in the evaluation of the LSITC approach.  
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The first evaluation was to assess the similarity and deviation between the two resulting k1 maps 
within the liver.  The similarity was tested by the linear correlation coefficient between the two 
k1 maps.  The deviation was evaluated by the weighted mean absolute percent error (WMAPE), 
where we define the voxel-wise weighted absolute percent error (WAPE) as  
|𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒(𝑖)−𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒(𝑖)|
1
𝑁
∑ 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒(𝑛)𝑛=𝑁𝑛=1
.     (2.12) 
Where i and n are voxel indices, and N is the total number of voxels considered.  It should be 
noted that this metric places higher weight on accuracy for larger measurements. In this case the 
DITC model uptake rates are the reference values. 
The second evaluation was to assess the validity of the LSITC model as applied to the clinical 
multi-phase LTR MRI data.  Due to the low temporal resolution of approximately 20 seconds, 
the arterial input function peak could be missed or averaged over 20-second sampling. The 
sampling of the arterial peak affects the integral of the arterial input function in equation (2.10).  
Considering that the integral is over a long time period of 10 to 20 minutes, the effect of the 
arterial peak on the k1 estimation could be small.  To evaluate it, a tissue concentration curve 
with a temporal resolution of 1/s was simulated by direct application of the DITC model, subject 
to the input of reasonable parameter values and blood concentration curves. To mimic the LTR 
multi-phase MRI data, a subsampled curve was created by removing all points after the 1st pre 
contrast point and prior to the peak of the arterial input function. This curve was used to assess 
the error inherent in neglecting to sample the upswing in the arterial function, even when the 
image was perfectly timed to correspond to the peak. In order to evaluate the additional bias 
incurred by mistiming the peak, an additional concentration curve was created by removing all 
post-contrast data until 20 seconds after the arterial peak. This mimics a 20-second delay in the 
ideal time to image the arterial peak.  For each of these three cases, the primary metrics were the 
correlation coefficients and WMAPE.  The error in the k1 estimation could represent an upper 
bound on the error incurred by missing the arterial peak, since acquisition delays longer than this 
would be easily visually recognizable.   
The third assessment involved the application of the LSITC approach to the clinical multi-phase 
MRI data and comparison to global liver function as measured by the ICG retention rates. These 
clinical scans were much sparser temporally than those seen in the HTR DCE scans and so fitting 
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with the full DITC model was impractical. The metric for evaluation was the correlation 
coefficient between the sum of the estimated K1 values over the contoured liver volume by the 
LSITC approach and the log of the ICG retention score, where K1 = k1Vdis.  In the sum of K1 over 
the whole contoured liver volume, outliers having K1 values above the 95
th or below the 5th 
percentiles were rejected to remove edge effects. Additionally, large vessels were excluded by 
rejecting voxels where vdis was greater than 0.4. The inclusion of the volume term ensures both 
uptake rate and plasma flow are accounted for.  The summation of a regional measure of liver 
function to allow comparison to a global function such as ICG is not new.28 
 
The final assessment involved comparison of the k1 values obtained in the HTR DCE, and LTR 
multi-phase MRI data sets to reported values of k1 in the liver from prior studies. 
 
2.3 Results 
2.3.1  k1 estimations by the LSITC model vs. DITC model 
Maps of k1 values estimated from the liver HTR DCE scans using both the LSITC and DITC 
models are shown in Figure 2.3.  
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Figure 2.3. Example slices of the k1 maps estimated from the HTR DCE scans of four patients by the linearized single-input two-
compartment model (left) and dual-input two-compartment model (right). Note that the units are mL/100mL/min. 
The linear correlations between the k1 maps estimated by the two models are shown in Figure 
2.4. The correlation was calculated in a randomly selected 5000 voxels within each liver, 
restricted to the voxels where vdis was above the 25
th and below the 75th percentiles, and the k1 
values were greater than 0.01 mL/100mL/min.   (In one patient who was a candidate for the liver 
transplant and had very poor liver function, there was a small volume in the liver that had the 
non-zero k1 values, leaving little volume for analysis.  Thus, this patient was excluded from the 
analysis described here). The correlation coefficients ranged from 0.98 to 0.76 with a median of 
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0.91.  The WMAPEs ranged from 9.0% to 39.4% with a median of 17.2%. Note that either 
estimate can be considered as the ground truth.  
 
Figure 2.4. Scatter plot of the k1 values estimated by the two models for the 8 patients.  The k1 values in the horizontal axis were 
estimated from the dual-input 2-compartment model and the ones in the vertical axis from the linearized single-input two-
compartment model. 
The estimated transition times (tp) when the varied from 10 to 313 seconds as measured from the 
peak of the arterial input function, with a median value of 58 seconds. The computation speed of 
the LSITC approach was approximately 1000 times faster than the dual-input two-compartment 
model, taking a few seconds per exam while the DITC model fitting took several hours per 
exam. 
2.3.2 k1 estimation by simulation of missing the arterial peak  
To simulate DCE data, composite input curves were first created by averaging the respective AIF 
and PVIF after matching the arterial peaks and re-sampling the time curves from all patients. The 
composite functions converged approximately 75 seconds after the arterial peak. To reduce noise 
the input data at least 5 min subsequent to the arterial peak was replaced by a double exponential 
fit.  
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Simulated parameters were randomly chosen but uniformly distributed over the ranges shown in 
Table 2.2, while τa and τpv were assumed to be 0 seconds. Using these values and the composite 
input concentration curves (AIF and PVIF), the resulting tissue concentration curves were 
calculated using the dual-input two-compartment model. 
Table 2.2. The ranges of the parameter values for the simulation, where kpvp = kpv(1-Hct) and kap = ka(1-Hct). 
Parameter Minimum Value Maximum value  
vdis 10 20 % 
kpvp+ kap 50 300 mL/100mL/min 
kpvp 0.5(kpvp+ kap) (kpvp+ kap) mL/100mL/min 
k1 0 0.1(kpvp+ kap) mL/100mL/min 
 
To assess the potential error and variance incurred by missing the arterial peak during the clinical 
multi-phase MRI scan, the resulting tissue and arterial functions (Figure 2.5a) were then 
subsampled to remove all points prior to the arterial peak, apart from one pre contrast reference 
scan (Figure 2.5b).  Furthermore, the data points acquired 20 seconds after the arterial peak 
(including the peak) were removed from the simulated curve and AIF to mimic a possible further 
delayed acquisition in the clinical data (Figure 2.5c).  
 
Figure 2.5. Early section of the AIFs to demonstrate subsampling used to investigate delays in acquisition. a) shows an AIF with 
the full dataset, b) shows an AIF with missing data points prior to the arterial peak, and c) shows an AIF with missing data 
points up to 20 seconds after the arterial peak. 
For each scenario tp was assumed to be 60 seconds post peak. The simulation was run 10,000 
times per case. A strong correlation was found between the LSITC results and input simulation 
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values. Without noise, correlation coefficients remained above 0.99 for all three cases including 
the case with an acquisition delay of 20 seconds after the arterial peak.  
Results showed similar distributions for estimates of k1, regardless of the acquisition delay (see 
Figure 2.6 and Figure 2.7). The WAPE in the noise free simulations was 4.7 ± 3.2% (mean ± 
standard deviation) for the full dataset, and then shifted to 6.1 ± 3.6% for the data missing time 
points before the arterial peak and to 6.7 ± 2.4% for the data missing time points up to 20 s after 
the arterial peak. The WAPE changed little when introducing white Gaussian noise to the 
generated Ct functions. Note that missing the early time points in the dynamic curves caused a 
maximum change in the WAPE of 2% (from 4.7% to 6.7% without noise), suggesting other 
effects predominate in the k1 estimation errors. Based on these results we would expect similar 
levels of systematic error resulting from delayed or averaged capture of the arterial peak in the 
LTR multi-phase data. 
 
Figure 2.6.  Plots of the input k1 values against the k1 values obtained by LSITC model. The correlation coefficient was R = 
0.999, 0,998 and 0.999 for the full dataset (a), the dataset missing time points prior to the arterial peak (b), and the dataset 
missing time points up to 20 seconds after the arterial peak (c) respectively. 
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Figure 2.7.  Boxplots for the WAPE in the LSITC model results relative to the simulated values at 3 noise levels for the three 
simulated datasets: a) the full dataset, b) the dataset missing data points prior to the arterial peak, and c) the dataset missing 
data points up to 20 seconds after the arterial peak. The median values are indicated by the horizontal line, the mean is indicated 
by the diamond, and error bars are 1.5 times the interquartile range. 
 
2.3.3 k1 estimation from the clinical MRI and comparison with ICG retention 
Maps of k1 and vdis were estimated from the clinical LTR multi-phase MRI of 27 exams using the 
LSITC model.  Example k1 and vdis maps are shown in Figure 2.8.  For the 20 clinical scans with 
accompanying ICG retention scores, the scores were compared to the K1 values (K1 = k1Vdis) 
summed over the contoured liver volume (Figure 2.9).  Voxels with vdis greater than 0.4 were 
rejected to omit vasculature, and K1 values less than the 5
th or greater than the 95th percentile 
were rejected to avoid outliers and edge effects. Since the log of ICG retention is inversely 
proportional to the rate of clearance in the liver, a linear relationship is expected. The sum of K1 
values were significantly correlated to the log of ICG retention values with a correlation 
coefficient of R = -0.72 (p=0.0004, n = 20).  
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Figure 2.8. Example maps of k1 and vdis in the assessed livers. Notice that high values of vdis can be seen to correspond to 
vasculature. 
 
Figure 2.9. Plot of the log of ICG retention at 15 minutes against the sum of K1 values in the contoured total liver volume. R = -
0.72 (p = 0.0004, n = 20). 
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2.3.4 Comparison to Literature values 
Maps of k1 values were generated for the 27 multi-phase LTR liver scans by the LSITC model. 
In each of the 27 k1 maps the mean value was calculated over the volume with vdis less than 0.4 
and with k1 values in the central 90
th percentile of k1 value for the liver. The mean value across 
all multi-phase LTR scans was 3.93 ±1.79 mL/100mL/min. Using the same process for the HTR 
DCE based maps the mean uptake was measured as 9.17 ± 8.23 mL/100mL/min, across all HTR 
DCE scans, and 7.44 ± 4.93 mL/100mL/min after removal of an outlier more than twice as large 
as any other mean uptake. It should be noted that the outlier was also the scan with the shortest 
total duration. 
This is fairly consistent with the prior literature. Previous studies have found mean uptake rates 
of 3.4 ± 2.1 in background regions of livers with metastases, 3.03 ± 2.1 in cirrhotic livers, 
and 6.53 ± 2.4 in healthy livers, as seen in Figure 2.1029,30.   
 
Figure 2.10. This plot shows the mean values obtained in several studies for background liver uptake rate of gadoxetic acid in 
cancerous livers, and a group of healthy livers for reference. Error bars indicate the standard deviation. The HTR values are 
based on a removed outlier. 
2.4 Discussion 
This chapter developed a LSITC model to quantify k1 from dynamic gadoxetic acid enhanced 
MRI in the liver, and evaluated the results by comparisons to an established uptake model, and 
measure of whole liver function.  The k1 values estimated by the LSITC and DITC analysis of 
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the HTR DCE MRI data had a close median correlation (R = 0.91). Application of the LSITC 
approach to LTR multi-phase MRI data gave similar results to prior studies and correlated 
relatively well (R = -0.72) with the results of ICG retention exams. Furthermore, concerns about 
the impact of delayed imaging of the arterial peak were addressed by simulations showing less 
than 3% related error. The results indicate that the LSITC model is a simple analog to the dual-
input two-compartment model, and correlates well with independent scores of liver function. 
Since this technique can be applied to clinically typical multi-phase data, it presents the 
possibility of quantitative liver assessment without large changes to existing clinical workflow. 
There are several possible sources of error in the determination of k1 via the LSITC model set 
forth here. It should first be noted that unlike the Patlak model, the ratio of k1 to k2 should not 
impact the estimate of k1, since the k2 dependent term cancels in equation (2.10) when dividing 
slope by intercept. However, this term will impact the estimate of vdis and K1, with both 
underestimated. This also suggests a more complete linear model where equation (2.8) is fit to 
determine k1, k2 and vdis, allowing a more accurate estimate of K1 (see appendix B). 
The model assumes that after tp, Cpv = Ca. In most of the measured input curves Ca and Cpv were 
very similar within less than a minute of the arterial peak. In some cases this held true after a 
constant correction factor, i.e. Cpv × constant = Ca. This could reflect differences in Hct between 
Ca and Cpv. In quantification of Ca and Cpv, native T1 of plasma was not considered since images 
for T1 quantification are almost never acquired in clinical liver scans.  However, native T1 of 
plasma should be the same for Ca and Cpv. This omission should not contribute to the difference 
between Ca and Cpv.  In general, it is anticipated that the peak of Cpv is shallower and broader 
than that of Ca, since the bolus of contrast travels through the vascular systems of intestines and 
spleen before it slowly returns to the portal vein through the mesenteric vein and splenic vein.   
In some patients, this contrast return seems to be slower than in others.  This could be a factor 
contributing to difference between Ca and Cpv even after the typical time tp.  However, partial 
volume effects and motion could also affect the measurement of Cpv, causing apparent 
differences between Cpv and Ca that do not reflect the actual contrast concentrations.  The 
simplified form of the model also neglects dCa/dt from equation (2.8). Since dCa/dt will 
generally be negative, and decreasing in magnitude after tp, we expect this to result in a small 
overestimate of vdis and k1. The possibility of flow related enhancement causing a 
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mischaracterization of AIF can be considered as well. Selecting the AIF values from an Aorta 
contour within 3 cm of the aortic split to the liver ensured the blood in the voxels used were far 
from the edge of the FOV, and had experienced multiple repetitions within the excitation 
volume. This minimizes the impact of flow related enhancement on the AIF, making this an 
unlikely source of error in AIF, or cause for differences between AIF and PVIF. The estimate of 
xp could also impact the final solution. Choosing xp too early would be expected to cause an 
underestimate of vdis, and an overestimate of k1. In the absence of noise even a very late estimate 
of xp should have little impact on the result. However, with noise we would expect additional 
uncertainty in the result as we estimate the slope and intercept from fewer data points.   
In the LTR clinical data we assumed the last three points after enhancement were after tp. This 
was necessary to have an overdetermined solution, but may not have been accurate in some 
voxels or livers. The time post arterial peak for the first point in the fit varied between 36 and 
290 seconds. The median time was 48 seconds. This can be compared to the optimal tp times 
chosen in the HTR data, which had a median of 65 seconds.  It should be noted that the peak in 
the LTR clinical data was assumed to coincide with the start of the first post contrast image, so it 
is possible that there is a hidden delay relative to the physiological arterial peak. Another 
possible source of error is the sparsity of the clinical data which causes an underestimate of the 
integral of Ca, and thus an underestimate of the values for x. We would expect this error to 
increase as the timing of the 1st post contrast measurement was delayed past the peak, but the 
change in error in the simulation was relatively minor, indicating other effects predominate.  
Both the LSITC and DITC models omit several notable features. Firstly, the models omit the 
excretion of contrast from the hepatocytes into the bile. It was assumed that the rate of excretion 
is negligible over the timeframe of the exams. Deviations from this assumption would cause 
error in k1 and thus impact the total functional estimate. However, this would not impact the 
comparison between the two models, or effect error in the simulated case. Secondly, the DITC 
model includes only one extracellular compartment, which may not be valid in tumors or other 
pathological tissues where movement between the capillary bed and the space of Disse is 
relatively slow. This would again impact both models. The impact could be assessed by 
comparison to a dual-input three compartment model.31 
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Contrast concentration for all exams was calculated using relative enhancement. Relative 
enhancement has been found to correlate linearly with the concentration in a given tissue, though 
this relationship breaks down at sufficiently high contrast concentrations.31  However, even if we 
assume perfect linearity and that all plasma and all liver voxels had uniform respective native T1 
values, the direct use of relative enhancement as relative concentration will introduce a constant 
bias term in the uptake rate based on the native T1 in plasma relative to liver tissue. This would 
not impact the correlation with liver function and could be fixed through a correction constant 
with knowledge of the ratio of native liver and plasma T1. If we further consider differences in 
native T1 across the liver we would expect additional error even in the relative voxel wise uptake 
rate. This could be fixed by characterizing the precontrast T1 with an additional sequence before 
contrast injection. Ideally this would allow for more accurate quantification of concentration, but 
does introduce clinical inconvenience and complicates analysis.  
In all real data; noise, motion and other random variation contributed to error in the input curves, 
and the tissue curves. Random variation will be especially harmful in cases where relatively few 
data points are used in the estimate of k1. Motion effects are especially apparent at the edges of 
the liver and liver vasculature. In these locations slight motion can cause apparent jumps in 
uptake as a motion artefact. 
Further work can be done to improve k1 quantification. For example, the impact of noise and 
motion could be lessened by the introduction of spatial regularization to the creation of the k1 
map. The full model from equation (2.8) can be used if k2, or vdis are parameters of interest, 
though it should be noted that the LSITC model cannot replace the DITC model when arterial or 
portal venous perfusion are parameters of interest. An evaluation of the impact of omission of 
native T1 on k1 estimation across the population of patients will be conducted.  Additional work 
should also use larger and more varied data sets to further characterize the relationship between 
liver function and uptake as measured by the LSITC model. Further analysis should also 
consider tissues in which the DITC model is insufficient and include comparison to a dual-input 
three compartment model.31 
2.5 Conclusion 
This Chapter proposes and validates the LSITC model for assessing liver function based on the 
uptake rate of gadoxetic acid.  Validation was obtained relative to the31 predictions of the 
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accepted dual-input two-compartment model, and independent measurements of whole liver 
function. The LSITC approach allows the creation of a spatially resolved quantitative image of 
liver function, using standard clinical acquisitions, and reduces the dependence on impractical, 
extremely high temporal resolution scans. 
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CHAPTER 3  
 
Validation of Gadoxetic Acid Uptake Rate as a Measure of Liver Function 
 
Significant portions of the results described in this chapter were previously described by the 
author in an abstract for the 2020 ASTRO annual meeting.32,33 
 
3.1 Introduction 
Global liver function has been shown to be an important clinical prognostic factor for RILD as 
well as overall survival in patients with cirrhosis and hepatic cancers1,3,34,35.  Liver injury during 
radiation therapy (RT) of hepatic cancers has been minimized using normal tissue complication 
probability (NTCP) models by limiting mean liver dose1–3.  To further minimize risks of liver 
injury, individualized adaptive RT strategies have been suggested and investigated.  Using this 
strategy, patients cannot be assumed to have the same liver function and the same response to 
radiation dose. Also, the distributions of hepatic function and dose-response in the liver volume 
cannot be assumed to be homogeneous4,6–8,36. These approaches require measures of global and 
regional liver function as well as radiation dose response in individual patients, and consider all 
these factors in treatment strategies and planning.     
 
We hypothesize that global as well as regional liver function can be quantified from a single 
measure using gadoxetic acid uptake rate (k1) from dynamic MRI. This chapter aims to validate 
k1 as a measure of both global and regional function through comparison with two established 
global function measures, ICG retention at 15 minutes (ICGR15) and raw albumin–bilirubin 
(ALBI) score5. Additionally, uptake is compared to portal venous perfusion (kpv) in relation to 
total function and spatial distribution. 
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3.2 Methods 
3.2.1 Data acquisition 
3.2.2.1 Patients.  Seventy-eight DGAE liver MRI scans were acquired from 40 patients (median 
age of 64 years) with liver cancers in prospective protocols approved by the University of 
Michigan Institutional Review Board.  All patients signed written consents.  The patient 
demographic information is given in Table 3.1.  The liver DGAE MRI scans were obtained pre-
RT and one-month post-RT.  Within no more than one week of the MRI scans, an ICG retention 
exam (a total liver function measure) was taken for all but 4 patients.  In total, 69 pairs of the 
DGAE MRI scans and ICG retention scores were available for correlation analysis of global liver 
function. 
3.2.1.2 Image acquisition.  3D volumetric DGAE MRI scans of the whole liver were acquired 
using a radial sampling VIBE sequence during the intravenous injection of a single standard dose 
of gadoxetic acid on a 3T scanner (Skyra, Siemens Healthineer). The free-breathing DGAE 
images of the liver used a 3D golden-angle radial stack-of-stars VIBE sequence that over-
samples the center of k-space and is resilient to motion effects37.  Acquisitions included image 
volumes from before contrast introduction to 4 to 31 minutes after the initial arterial peak 
(median 18 minutes). Dynamic image volumes of the whole liver were reconstructed with a 
temporal sampling rate of 3.4 to 15.2 seconds per volume (median 8.8 seconds), and 64 to 80 
slices with thicknesses from 2.6 to 4.8 mm and an in-plane resolution of 2.1×2.1 mm to 2.6×2.6 
mm (192 by 192 pixels).  
3.2.1.3 ICG retention test.  The ICG retention exam used a single dose of ICG with blood 
sampled at 5, 10, and 15 minutes following injection to measure the fractional retention of ICG. 
ICG is cleared almost entirely in the liver38,  making measures of ICG clearance a common 
surrogate for global liver function6. ICGR15 was used to test the global liver function calculated 
from the DGAE MRI scans. See reference 36 for a more in-depth description of ICGR15 
procedure. 
 
3.2.1.4 ALBI.  The ALBI score is computed using serum bilirubin and albumin levels using the 
equation given by Johnson et al5:  
ALBI = (log10(bilirubin) × 0.66) + (albumin × −0.085)   (3.1) 
  31 
with bilirubin in μmol/L and albumin in g/L. Though this score can be used rate the patient’s 
liver function with a discrete ALBI grade, the raw ALBI score is a continuous measure. This raw 
ALBI score was used as an additional measure to test the global liver function calculated from 
the DGAE MRI scans. 
Table 3.1. The patient demographics for all 40 patients 
Characteristic Value 
Age (years): median (range) 64 (48 to 100) 
Sex: female/male 9/31 
Pre-treatment Cirrhosis (%) 82.5 (33 of 40) 
HCC (%) 85.0 (34 of 40) 
Liver Volume (L): median (range) 1.80 (0.69 to 3.99) 
GTV Volume (mL): median (range) 43 (2.7 to 1251) 
Child-Pugh Score: median (range) 6 (5 to 10) 
Raw ALBI Score (n=37)  
Pre-RT: median (range) -2.2 (-3.6 to -1.0) 
Post-RT: median (range) -2.0 (-3.27 to -1.0) 
ICGR15 (%) (n=35)  
Pre-RT: median (range) 29.2 (4.0 to 82.3) 
Post-RT: median (range) 40.6 (7.5 to 82.3) 
 
 
3.2.2 Image processing and analysis 
3.2.2.1 Image pre-process and model fitting.  The time-series DGAE-MRI volumes were co-
registered within the liver contour using an over-determined, rigid-body transformation 
approach15. Then, both DITC and LSITC models were applied to the registered time-series 
DGAE-MRI volumes to estimate kpv, k1 and vdis,  using respective NLLS and LLS fitting 
implemented in Matlab, as described in chapter 2.  
 
3.2.2.2 Similarity between perfusion and uptake rate maps.  To assess whether portal venous 
perfusion (kpv) could be used as a surrogate for liver function, the correspondence between 
uptake rate (k1) and portal venous perfusion (kpv) was investigated using the ranked Spearman 
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correlation.  Both kpv and k1 maps were obtained from NLLS fitting of the DITC model. 
Additionally, the expected differences of vasculature in the evaluation should be excluded, so all 
regions with a blood distribution volume (vdis) >0.25 were omitted from comparison. A binned 
comparison of quantiles of the two maps was performed for visual comparison of the relative 
distribution of the measures. To this end, all maps were divided into 100 quantiles, and 
normalized to 0 through 1 for inspection. 
 
3.2.2.3 Global liver function measures derived from imaging.  If global and spatially-resolved 
liver function measures could be derived from a single measurement, e.g., imaging, it would 
reduce redundant measures.  There are several plausible or proposed ways of constructing a 
global measure of liver function from imaging. A simple measure would be the mean kpv in the 
liver13. A total functional volume would be calculated by incorporating the liver volume with the 
uptake rate (k1) as a sum of k1Vt across the liver, or equivalently mean k1 by total volume: ?̅?1VL . 
A prior study suggests that the blood distribution volume that provides the surface area for the 
gadoxetic acid uptake by parenchyma might be considered in the functional volume 
computation, instead of using the absolute liver volume22. This measure would be expected to 
correspond to the total rate of gadoxetic acid uptake as a sum of K1=k1×Vdis.  Finally, a total liver 
volume, which is a conventional measure used in liver resection39, could be included for 
comparison.  All four imaging derived candidates of global liver function measures were tested 
by a linear regression with a well-established global liver function measure, ICGR15, as well as 
a more recently established measure: ALBI score5.  Also, these linear regressions serve as a 
calibration measure to compute global liver function from DGAE MRI.  Since the rate of ICG 
clearance is proportional to the log of ICG retention, a linear relationship would be expected 
between the log of ICGR15 and a measure of liver function. 
 
The initial three tested global liver function measures: 1) mean k1×total volume (mL/min), 2) 
summed K1, and 3) mean kpv were calculated in the contoured liver volume with uptake rates > 0 
mL/100mL/min, and distribution volumes 0.02<vdis<0.25 to exclude the liver contour variation 
and blood vessel. The final measure, 4) the volume, included the entire contoured liver volume 
minus the gross tumor volume (GTV). Since several of these measures is based on a totaled 
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capacity in the liver (1,2,4), it may be of use to quantify this relative to patient size. To this end, 
each measure was also compared to ICGR15 and ALBI score after normalization by patient mass 
3.3 Results 
3.3.1 Similarity between perfusion and uptake rate maps 
 
Figure 3.1. Example slices of k1 (top row) and kpv maps (bottom row) presented in 100 quantiles of 4 patients with different 
ICGR15 and ALBI values. Note that large vessels generally show as dark in uptake rate maps (lacking hepatocytes), while in 
perfusion maps they can be either dark (arterial vessels) or bright (portal venous vasculature), depending on the type of vessels. 
Note that k1 maps were derived from the LSTIC model while kpv maps were derived from the DITC model. 
Portal venous perfusion and uptake rate varied greatly between patients as well as within 
patients.  Example slices of k1 and kpv maps of 4 patients with different ICGR15 scores are 
shown Figure 3.1. The four patients had ICGR15 of 31.5, 82.3, 9.1 and 16.8%, ALBI scores of  -
1.65, -1.29, -3.02, and -2.60,  and correlation coefficients of 0.34, -0.34, 0.27, and 0.15, 
respectively.  Note that the differences were pronounced on a larger scale in some patients, 
especially for the patients with very poor liver function.  The second left column in Figure 3.1 
shows that a patient with ICGR15 and ALBI of 82.3% and -1.29 had a negative correlation of -
0.34 due to negligible uptake rate of gadoxetic acid throughout the majority of the liver, but 
relatively healthy perfusion through the liver. 
In 26 of the 79 DGAC MRI scans, kpv maps had extremely low values with local variation 
resembling noise.  In these cases we observed a mean kpv < 0.005 mL/min/(100mL) , but 
typically much lower, compared to typical values of 10 to 60 mL/min/(100mL) from other 
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patients. It is conceivable that this was caused by the existence of cirrhosis and HCC in the 
patients or, more likely, by unreliable estimation of kpv in the cases with poor hepatic perfusion 
using one standard dose of gadoxetic-acid (in which Gd counts are one quarter of the counts in 
one standard dose of Gd-DTPA) and using the DITC model.  To make the comparison fair, the 
26 instances with negligible perfusion were excluded from the analysis of the correlation 
between kpv and k1. 
In the remaining 53 exams, the correlation was still poor on average. The mean ranked 
correlation between uptake rate and perfusion maps was R = 0.095 (median: 0.12  range: -0.45 to 
0.56). Figure 3.2 shows the distribution of ranked correlations between k1 and kpv values. Note 
that there were only two exams that showed a positive correlation greater than 0.4.  Nearly a 
third to one half of the exams had negative or near zero correlation between k1 and kpv in the 
liver, indicating a mismatch or non-match between hepatic perfusion and liver function.  
 
Figure 3.2. histogram of the distribution of ranked correlations between k1 and kpv values (mean: 0.095, median: 0.12, n=53). 
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3.3.2 Imaging derived measures of total liver function compared to ICG and ALBI 
To determine which imaging derived measures were reliable as a measure of total liver function, 
these measures were compared to an independent measure of total liver function, ICGR15. 
 
3.3.2.1 Uptake derived measures. The total function volume (measure 1 from 3.2.2.3), quantified 
by the product of the mean k1 in the liver and the total liver volume (determined using the LSITC 
model) had a strong correlation with both ICGR15 and ALBI (R = -0.67 with 95% confidence 
interval (95% CI) of [-0.79 -0.53] and R = -0.73  (95% CI) [-0.82 -0.59] respectively), see 
Figures 3.3a and 3.4a.  To calibrate the total function volume against ICGR15, a linear 
regression model was tested after the removal of an outlier (k1 >3 median absolute deviations 
from the median), see Table 3.2. Normalization by patient mass resulted in strengthened 
correlations (R=-0.76, 95% CI [-0.84 -0.64] and R=-0.75, 95% CI [-0.84 -0.62] for ICGR15 and 
ALBI respectively), with the corresponding fits given in Table 3.2. 
 
The summed K1 (measure 2 from 3.2.2.3, accounting the total blood distribution volume, instead 
of the total liver volume) correlated well to ICGR15 and ALBI (R=-0.61, 95% CI [-0.73 -0.42], 
and R=-0.71, 95% CI [-0.81 -0.57]) but weaker than expected for ICGR15 based on preliminary 
studies22 or the apparent analogy between total K1 and ICG uptake rate.  There appeared to be 
approximately 10 exams that had log10(ICGR15) values near 1 but had a systematic deviation 
from the regression line, see Figure 3.3b. This pattern was not seen in the corresponding ALBI 
scores. The linear regression models are given in Table 3.2. Normalization by patient mass again 
resulted in strengthened correlations (R=-0.69, 95%CI [-0.79 -0.54], and R=-0.74, 95% CI [-0.84 
-0.63]). 
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3.3.2.2 Perfusion derived measure. The correlation between mean kpv (measure 3 from 3.2.2.3) 
and both log10(ICGR15) and ALBI was poor.  23 exams were removed from the correlation 
analysis due to a failure in fitting kpv as seen by extremely low kpv values across the liver volume.  
In these 23 exams, there were no voxels that had kpv values greater than 0.6 mL/(100mL min) 
and less than 300 mL/(100 mL min) (artifacts). Without these two limits in place the fit was 
dominated by extreme outliers. As seen in Figures 3.3d and 3.4d and Table 3.2, there was not a 
significant correlation between mean portal venous perfusion and ICGR15 or ALBI (R=0.03, 
95% CI [-0.26 0.32] and R=0.06, 95% CI [-0.24 0.35]). 
 
3.3.2.3 Volume derived measure. Liver volume (measure 4 from 3.2.2.3) showed a moderate 
correlation with log10(ICGR15) (R = -0.30, 95% CI [-0.50 -0.06]), which was similar to 
preexisting studies28,40,41(see Figure 3.3d and Table 3.2), and comparable correlations for ALBI 
(R = -0.40, 95% CI [-0.58 -0.18]) (see Figure 3.4d and Table 3.2). Only the ICGR15 correlation 
was strengthened by normalization by patient mass (R=-0.39, 95% CI: [-0.57 -0.17]). The 
correlation for mass normalized liver volume and ALBI showed an apparent strengthening of the 
linearity of the relationship for most points, but created several outliers that canceled out this 
effect (R=-0.40, 95% CI: [-0.58 -0.17]). 
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Table 3.2. Linear Regression Models of Imaging Derived Total Liver Function Measures to ICGR15 and ALBI.  
Measure Used to 
Predict 
log10(ICGR15) 
 
R Slope (95% CI) Intercept (95% CI) 
?̅?pv [/s] 0.03 0.0838 [-0.64 0.81] 1.51 [1.26 1.75] 
?̅?1VL [L/min] -0.67 -2.97 [-3.63 -2.31] 1.74 [1.66 1.83] 
?̅?1VL/W [L/min/kg] -0.76 -308.5 [-362.6 -254.6] 1.79 [1.72 1.87] 
Summed K1 [L/min] -0.61 -14.85 [-19.29 -10.40] 1.67 [1.58 1.76] 
Summed K1/W 
[L/min/kg] 
-0.69 
-1749 [-2167 -1330] 1.73 [1.64 1.81] 
VL [L] -0.30 -0.145 [-0.26 -0.03] 1.71 [1.50 1.92] 
VL/W [L/kg] -0.39 41.84 [-56.44 -27.24] 2.21 [1.94 2.48] 
Measure Used to 
Predict ALBI 
 
R Slope (95% CI) Intercept (95% CI) 
?̅?pv [/s] 0.06 0.3155 [-1.25 1.88] -2.06 [-2.60 -1.52] 
?̅?1VL [L/min] -0.73 -6.7242 [-8.00 -5.45] -1.45 [-1.60 -1.29] 
?̅?1VL/W [L/min/kg] -0.75 -604.7 [-723.3 -486.1] -1.44 [-1.60 -1.28] 
Summed K1 [L/min] -0.71 -38.50 [-47.07 -29.94] -1.56 [-1.72 -1.40] 
Summed K1/W 
[L/min/kg] 
-0.76 
-4215 [-5027 -3403] -1.46 [-1.62 -1.30] 
VL [L] -0.40 -0.38 [-0.59 -0.16] -1.42 [-1.83 -1.01] 
VL/W [L/kg] -0.40 -105.1 [-129.2 -81.11] -0.23 [-0.67 0.22] 
Least squared fitting  of the Global measures (log(ICGR15) or ALBI) from the given measure using the equation: Global 
Measure = Slope×measure + Intercept. The fits ignore the outliers marked in figures 3 and 4. W represents the patient weight. 
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Figure 3.3a-3g log10(ICGR15) plotted against: (a) mean k1 by Total Volume, (b) summed K1 = summed k1Vdis, (c) total liver 
Volume outside GTV, (d) mean kpv, (e) weight normalized mean k1 by Total Volume, (f)) weight normalized summed K1 = 
summed k1Vdis, (g) ) weight normalized total liver Volume outside GTV.  The plotted linear regression fit in (a), (b), (e), and (f) 
each ignore one outlier in terms of k1, and the fit for (g) ignores 4 outliers in terms of weight normalized liver volume. 
Correlation coefficients do not exclude outliers 
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Figure 3.4a-4g.  The raw ALBI plotted against: (a) mean k1 by Total Volume, (b) summed K1 = summed k1Vdis, (c) total liver 
Volume outside GTV, (d) mean kpv, (e) weight normalized mean k1 by Total Volume, (f) ) weight normalized summed K1 = 
summed k1Vdis, (g) ) weight normalized total liver Volume outside GTV.  The plotted linear regression fit in (a), (b), (e), and (f) 
each ignore one outlier in terms of k1, and the fit for (g) ignores 5 outliers in terms of weight normalized liver volume. 
Correlation coefficients do not exclude outliers. 
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3.4 Discussion 
This chapter evaluated four potential measures of liver function against two well regarded 
measures of global liver function.  The analysis shows that the total function volume quantified 
from the DGAE-MRI, which accounts for both liver volume and gadoxetic acid uptake rate, is a 
better measure for global liver function than mean portal venous perfusion or liver volume, 
especially in the patients with a mis-match between hepatic perfusion and functional 
parenchyma.  This single imaging technique can be used for measures of both global and 
regional liver function, and aid in liver function preservation during adaptive radiation therapy of 
hepatic cancers.   
 
The results of this analysis underscore the differences between total functional volume and liver 
volume. While in most metastatic cases we expect liver function to be uncompromised and 
relatively homogeneous outside the region of the tumor, this is not a safe assumption for patients 
with primary liver cancer, and risks overestimation of functional liver volume.  As previously 
mentioned, patients treated for HCC are likely to have preexisting cirrhosis, resulting in 
significant compromise to liver function outside regions directly affected by the tumor. In this 
work the correlation between liver volume and total function measured by ICG was similar to 
prior studies 28,40,41.  The correlation with ALBI was similar. There is obvious and undeniable 
evidence that non-functional volume cannot contribute to liver function.  However, this is not the 
end of story without accounting for the extent of liver function. While global measures of 
function such as ICGR15 allow for patient specific prediction of functional reserve, RILD or 
liver toxicity, thus enabling adaptation in treatment1,36, regional functional measures open the 
door to even more intricate tailoring of treatment plans. 
 
Dynamic gadoxetic acid enhanced MRI scans allow for assessments of the extent of hepatocyte 
function through contrast uptake, rather than assuming uniform function or interrogating the 
“plumbing” of the liver as in perfusion studies. Quantitative assessment of the extent of function 
in the regional units (voxels) allows one to compute a sum of the function of units as a measure 
of global liver function. Various models can be used to get the uptake rate (e.g. DITC, LSITC, 
DITC with bidirectional exchange or efflux terms). The robustness of these models is of critical 
importance in ensuring a well-informed treatment plan for every patient, with minimal time 
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waiting for the patient (whether to receive or finish a procedure). While both intuition and a prior 
study had indicated that the summed volumetric uptake rate would correlate well with global 
function, a stronger correlation was found for k1VL (measure 1) than for k1Vdis (measure 2), 
though both had decent (R>0.6) correlations to log10(ICGR15).  A similar picture was seen for 
ALBI, though the distinction between k1VL and k1Vdis was less pronounced. It should be noted 
that while in this chapter both measures (k1 and K1=k1*vdis) were computed using LSITC 
analysis, the same calculations based on the DITC model gave similar results (differing by no 
more than ±0.05). Both uptake based measures benefited from normalization by patient weight, 
particularly when compared to ICGR15.  
 
In addition to the measures explicitly compared in this chapter, there are other measures that 
could be derived from dynamic gadoxetic acid enhanced MRI, such as hepatic extraction fraction 
(HEF), and liver to spleen ratio (LV/SLV).  HEF and LV/SLV have shown promise in prediction 
of global liver function23,28,40–42, though these studies have tended to be among patients with 
healthier ICG scores. A notable feature of uptake rate, unlike measures such as HEF and 
(LV/SLV), is that it differentiates contrast enhancement due to uptake by parenchyma from 
contrast in blood plasma and fluid and doesn’t assume conformity to flow enhancement in the 
spleen. While semi-quantitative measures (e.g., LV/SLV) benefit from simplicity, they are 
machine dependent measures43. The primary drawbacks of hepatocyte transport indices like k1, is 
the acquisition and analysis complexity43, which can be mitigated through approaches such as 
LSITC. A previous study44 that performed a VOI-based uptake rate calculation using a different 
method (that was also a simplification of the DITC model designed for improving robustness of 
the estimation) found a moderate linear correlation (r = -0.429, P = 0.023)) between ICGR15 and 
uptake rate in a comparatively healthy patient sample (median ICGR15 was 12%  with a range of 
0.9 to 52%, compared to a pretreatment median of 29.2% and range of 4% to 82.3% in the 
present work). Note that the volume based uptake rate calculation has several differences 
compared to our functional volume calculation.   First, equation (2.10) indicates that averaging 
the concentration time-curve in the liver volume to calculate uptake rate does not produce an 
averaged k1 in the volume due to the spatial variation in the distribution volume (vdis).  Second, 
the volume-based k1 computation does not account for the volume contribution into global 
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function. Third, the volume-based k1 does not provide regional liver functional distribution.  All 
these differences affect the global liver function computation using DGAE MRI scans. 
 
Previous work has shown a strong correlation between global function and mean perfusion13,17. 
However, these studies have had relatively small sample population with higher liver function, 
and lower rates of HCC and cirrhosis as compared to this work. These studies found linear 
correlations of 0.70 (17 patients), and 0.92 (9 patients) between ICG rates and mean global kpv, 
but had a lower representation of patients with HCC, and, predictably, lower rates of respective 
pre-treatment cirrhosis 35%, and 11%, compared to 83% in the present work. A similar reality 
can be observed in ICGR15 where the two prior studies had respective ICGR15 ranges of  6.72 
to 53.18%, and 9.92 to 34.43%, compared to 4.04 to 82.3% in this work. While cirrhosis does 
result in compromised portal venous perfusion45, that doesn’t necessarily indicate that the level 
of functional compromise is predictable via the level of compromise in perfusion.  
The removal of vascular regions is instructive in this point. The mere presence of perfusion in 
those regions is not indicative of healthy uptake. Correspondingly, it is entirely possible for 
losses in functional hepatocytes to be mismatched from the restriction in perfusion as disease 
progresses (see the second column of figure 3.1). Wang et al16 used portal venous perfusion to 
create functional probability maps, with a good correlation to ICG rates. However, their analysis 
showed increased uncertainty for patients with HCC, which is consistent with the failure in this 
work to replicate the strong correlations found between ICG retention rates and mean perfusion 
in healthier, non-cirrhotic patient populations. Taken together with the indications of Wang et al, 
the results of this work would indicate that for populations with poor liver function and cirrhosis, 
the mean perfusion is not a reliable indicator of global function, and that the regional perfusion is 
not a reliable indicator of regional function.  
These indications should be understood to have limitations. Firstly, we should note the difficulty 
in fitting the DITC model. It is possible that reliable functional prediction from portal venous 
perfusion requires more precise temporal characterization of the portal venous and arterial input 
functions, or a stronger signal for these input functions than is typically observed in DGAE MRI. 
It was certainly the case that many exams were not successfully fit via the DITC model, which is 
unsurprising given its complexity. We should particularly expect difficulty in differentiating ka 
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and kpv when Ca and Cpv are very similar, with the first few minutes of acquisition containing the 
salient differences. In cases where perfusion is the desired measure, gadobenic acid would be the 
preferred contrast, but it is not a hepatobiliary contrast agent, which precludes analysis of uptake 
rate. Use of gadoxetic acid in this instance allowed for direct comparison in a single scan without 
additional registration considerations and is certainly justified in any acquisition where regional 
liver function is the desired measure.   
 
Portal venous perfusion may also have a more complex relationship with function than 
characterizable through linear a correlation, so that a  more complex statistical model such as that 
performed by Wang et al could derive better predictions of function, but we must recognize that 
any measure based upon portal venous perfusion is an indirect measure of function, and the 
results of Wang et al similarly indicate increased uncertainty in cirrhotic patients.  
 
Further work is necessary to determine the degree to which functional avoidance therapy can 
increase the retained liver function over perfusion based functional avoidance therapy, or mere 
minimization of mean liver dose. Significant gains would be expected in cases with highly 
spatially distinct high and low functioning areas outside the tumor region.  However, in cases 
where function is distributed uniformly, or the treatment plan is already determined by organ at 
risk constraints, a significant reduction in dose to highly functional areas may be infeasible. 
3.5 Conclusion 
Gadoxetic uptake is promising not only for regional assessment of liver function, but also as a 
means of estimating global function, and “functional reserve”. This is particularly true in cases 
where liver function is highly compromised and heterogeneous, where the uptake based 
measures were most reliable. 
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CHAPTER 4  
 
Impact of Mismatch between Liver Function and Hepatic Perfusion on Functional 
Avoidance Treatment Planning 
 
The results described in this chapter were previously described by the author in an abstract for 
the 2018 AAPM annual meeting.46 
 
4.1 Introduction 
One strategy to preserve overall liver function during radiation therapy is to optimize the 
treatment plan to avoid highly functional regions and push residual doses to regions with 
relatively poor function. Although the ultimate clinical benefit of functional avoidance treatment 
planning requires demonstration through a clinical trial, the actual “functional” map that ought to 
be used in functional avoidance planning is an important question to address. This chapter 
evaluates the radiation dose reduction in the liver from functional avoidance treatment planning 
compared to standard planning, and compares the impact of mismatch between regional hepatic 
perfusion and hepatocyte uptake of gadoxetic acid in functional avoidance treatment planning. 
 
4.2 Methods 
To assess differences between gadoxetic-acid uptake rate and hepatic perfusion on functional 
avoidance treatment planning, functional avoidance treatment plans were created in 10 patients 
using the pre-RT scans (3 Female; 6 with HCC and Cirrhosis). Total hepatic perfusion (k2) was 
chosen as a more robust measure than kpv, noting that kpv would be expected to be the dominant 
component of hepatic perfusion (kpv should be 2-3 times ka)
20.  Ten patients were selected across 
the range of similarity between k2 and k1. Perfusion and uptake rate maps were created as 
measures of localized liver function, following the procedures described in chapter 2 for the 
DITC and LSTIC models respectively.  
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The goal of functional avoidance treatment planning is to spare the best functioning regions in 
individual patients (a property of relative function). Therefore, the perfusion and uptake maps 
were thresholded to create function sparing, non-sparing and intermediate regions for each 
patient. A representative normal functioning region was manually selected in each patient. 
Voxels with uptake rate (or perfusion) >80%,  >36% but <80%, and <36% of the normal value 
were designated as function (or perfusion) sparing, intermediate, non-sparing regions, 
respectively.   This strategy also mitigates the influence of local uncertainty of perfusion and 
uptake rate maps on the optimization of treatment planning. 
These MRI derived regions were rigidly registered to the treatment planning CT in Eclipse 
treatment planning system (Varian Medical Systems). Three VMAT plans were created per 
patient: (i) a liver volume sparing plan minimizing dose to all liver tissue outside the tumor 
volume, (ii) a function based plan minimizing dose to function sparing regions, and (iii) a 
perfusion based plan minimizing dose to perfusion sparing regions.  
 
Each plan was designed to deliver 55 Gy, in 5 fractions.  Priority one objectives for all plans 
included SBRT dose limits for OARs and Liver NTCP.  The NTCP model used predicts the 
likelihood of 2-point increase of Child Pugh (CP) Score within 3 months of RT, CP score has 
been shown to be important in assessing radiation induced toxicity47. Plans were compared based 
on the mean dose to the sparing regions, with particular note given to the reduction in mean dose 
relative to the liver volume sparing plan. 
 
4.3 Results 
The selected 10 patients for function sparing treatment planning had ranked correlation between 
k2 and k1 ranging from 0.54 to -0.58 (Figure 4.2), which represented the cohort of patients well.  
Examples of quantile uptake rate and perfusion maps for function sparing treatment planning are 
shown in Figure 4.1.  The mean doses in the regions that were considered for function sparing 
(the regions with k1 values greater than >36% of the “normal” value in each patient exam) were 
compared between the liver volume plan, k1 based sparing plan, and k2 based sparing plan in 
each patient, as shown in Figure 4.2.  Overall, k1 and k2 based sparing plans resulted in the 
similar mean dose reductions in the function regions (>36% of the individual k1 “normal” value) 
as 12.7% (11.8 SD) and 11.5% (13.3 SD), respectively.  Compared to the liver volume plan, k1 
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based plan yielded a mean dose reduction in the function region greater than 1Gy (or indeed 1.5 
Gy) in only 4 patients (#2, #6, #7 and #10 in Figure 4.2).   For the most mismatched case, the 
function based plan provided an additional 10.1% reduction in the mean dose to function sparing 
regions comparing to using the perfusion based plan. An example case of three plans, liver 
volume based, function based and perfusion based, are shown Figure 4.3.  
Figure 4.1. A demonstration of sparing region binning and comparison between the sparing and non-sparing regions as defined 
by the function and perfusion maps (k1 and k2). With k1 derived from LSITC and k2 from DITC. Note profound differences in top 
and bottom images. 
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Figure 4.2. The mean dose to the function sparing region for the liver volume sparing plan, perfusion based plan, and function 
based plan. Ordered by the descending ranked correlations between maps of k1 and k2, with the correlations given above each set 
of columns. 
 
Figure 4.3. The dose distribution for the liver volume, function, and perfusion sparing plans for an example patient. Note that in 
this case the function and perfusion based plans are quite similar compared to the liver sparing plan. (Dose distribution not 
decipherable in greyscale). 
4.4 Discussion 
The summary statistics confirm that, as applied, both plans succeed in reducing dose to the 
specified regions. More interestingly, as applied, overall, either measure will tend to protect 
function as indicated by the other measure. While that is true overall, in individual cases where 
the mismatch is most extreme the differences can be quite profound (see figure 4.2).  
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It is worth considering the reasons for the relevant similarities and differences in sparing regions. 
Note firstly that there are obvious tissue types that will be evaluated very differently. Vascular 
regions will have high perfusion, but negligible uptake since they lack hepatocytes (see the 
bottom comparison of figure 4.1). This principle can be expanded to regions where hepatocytes 
would normally exist but have been compromised by a pathology. It is entirely possible that low 
uptake in these regions would correspond with normal perfusion. This is likely seen in the 
second patient highlighted in figure 4.2, where both gadoxetic uptake rate, and the ICG score 
showed compromised liver function (ICGR15 = 82.28%), but perfusion did not reveal an 
abnormality. In cases like this in particular we would expect treatment planning optimization to 
differ significantly, failing to reap the full benefits of functional avoidance treatment planning if 
our metric of function is perfusion. 
 
4.5 Conclusion 
Functional avoidance treatment planning with perfusion or uptake both result in dose reduction 
to regions with moderate perfusion or uptake.  However, there is potential for large mismatches 
that limit functional sparing.  A clinical trial is required to conclusively determine which method 
best preserves liver function. 
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CHAPTER 5  
Neural Networks for Robust Quantification of Gadoxetic-Acid Uptake Rate From 
Suboptimal Acquired MRI 
 
This chapter is substantially equivalent to work the author has already published in Medical 
Physics48. 
5.1 Introduction 
As discussed in prior chapters, gadoxetic acid uptake rate can be determined through fitting of 
the DITC model of gadoxetic acid kinetics, or the DITC derived LSITC model 20,22. These 
models are typically applied and validated using HTR DCE scans that collect volumes regularly 
enough to well characterize the concentration across time in the relevant regions, typically 
sampling every 5 to 15 seconds. However, the most common clinical gadoxetic acid enhanced 
MRI exams do not sample this comprehensively. Clinical multiphase scans are obtained for 
metastases detection and diagnosis. These clinical exams are typically LTR, with as few as 6 
volumes irregularly sampling 20 minutes of contrast kinetics. It should also be noted that clinical 
demands inevitably incentivize shortening exams. If quantification accuracy can be maintained 
or improved while shortening total acquisition time and eliminating the need for constant 
acquisition (e.g. LTR style acquisitions), the patient can be given equivalent care with less 
inconvenience and discomfort, and minimal change to common clinical workflows. 
This motivates the development of methods for accurate quantification of regional liver function 
from short and poorly characterized DCE MRI exams in a robust manner. This chapter develops 
an artificial neural network (NN) approach to predict k1 from LTR data. Furthermore, this 
approach uses data augmentation from a generative adversarial network (GAN) implemented to 
allow realistic and varied simulation of gadoxetic acid dynamics from the DITC model of 
gadoxetic acid kinetics in the liver. These approaches are compared to least squares fitting of the 
LSITC model22  as applied to both HTR and LTR data. We hypothesize that the new NN 
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approach allows faster and more convenient MRI acquisition without a sacrifice to the accuracy 
of functional maps sufficient to compromise treatment guidance. 
5.2 Methods 
A NN based approach is developed to predict k1 from LTR data derived from DCE scans. To 
counter the inherent granularity of the underlying input functions a GAN is used to generate 
input functions for the augmentation of NN training. The NN based approaches are compared to 
LSITC analysis for both well characterized HTR data, and the more limited LTR data with 
varied acquisition duration to assess robustness of the approaches. 
5.2.1 Data acquisition 
In order to assess error across analysis types and data characteristics, 3D volumetric DCE MRI 
of the liver were acquired during the intravenous injection of a single standard dose of gadoxetic 
acid using a Golden-Angle Radial sampling VIBE sequence on a 3T scanner (Skyra, Siemens 
Healthineer) in a prospective protocol approved by University of Michigan Institutional Review 
Board. 30 exams were acquired over a set of 22 patients (Age: 50 to 82 years, 6 female) with 
hepatocellular carcinoma. The 3D free-breathing DCE images of the liver were acquired using a 
3D golden-angle radial stack-of-stars VIBE sequence.  This sequence over-samples the center of 
k-space, and allows greater resilience to motion effects than other sequences37.  The time-series 
images were co-registered within the liver VOI using an over-determined, rigid-body 
transformation approach27. All acquisitions continued for 16-20 minutes after injection of a 
single-dose gadoxetic acid contrast and had temporal resolutions of at least 5 samples per 
minute.  
The acquired HTR data was subsampled to produce corresponding LTR data (Figure 5.1). This 
was done by interpolating (1) a pre-contrast volume, (2) 3 volumes spaced 25 seconds apart 
designed to capture the arterial and portal venous phases, and (3) two volumes at the end and 
midpoint of the acquisition (roughly 20 and 10 min, respectively). Ca, Cpv, and Ct were obtained 
as described in a Chapter 222.  
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Figure 5.1. Illustration of characteristics of densely sampled high temporal resolution (HTR – left) and more sparsely sampled 
low temporal resolution (LTR - right) datasets. HTR data is regularly sampled at 5-10 s intervals for the duration of 16-20 min. 
LTR data involves the acquisition of three post contrast samples uniformly spaced at intervals of 15 to 35 seconds, followed by 
two points, one at roughly 10 min and another at roughly 20 min post contrast. LTR data is the clinical norm. 
5.2.2 Least squares fitting of LSITC model 
LSITC analysis involved linear regression for the best fit to equation (2.10). For HTR data t0 was 
selected to maximize the linearity of the time range being fit, as described in chapter 2. In the 
analysis of the synthetic LTR data, t0 was chosen 75 seconds after the initial upswing of the 
arterial peak. In both cases the resulting estimate of k1 was the intercept normalized slope of the 
least squares linear fit from t0 to the final point. This allowed the linear fit to incorporate 3 points 
for the LTR data. 
5.2.3 Neural network – rationale and implementation 
Given a reasonable set of patients with k1 estimated from HTR data, a machine learning 
approach is a natural means for creating a prediction from a subset of that data, e.g., multiphase 
LTR data. To this end, a simple fully connected NN with 4 hidden layers (10,10, 5 and 5 
neurons) was trained on voxel-wise LTR data to predict k1 (Figure 5.2). Both the total 
acquisition length and the placement of points in the training data were varied considerably to 
encourage robustness to variation.  This was performed by having the arterial and portal venous 
phase points sampled uniformly 15 to 50 seconds apart, with uniformly distributed perturbation 
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up to 10% of the sampling period. The endpoint tend was randomly selected from a uniform 
distribution from 5 minutes after the arterial upswing until the end of the acquisition. The 
midpoint sample was selected from a uniform distribution from 0.25tend to 0.75tend. Each voxel 
then consisted of 5 pairs of values representing the x and y vectors calculated from equation 
(2.10) based on 5 post-contrast time points (as in the right panel of Figure 5.1). 
Training was performed by randomly selecting 3 million voxels in the livers from 30 exams, 
holding 3/5ths for training, 1/5th for validation, and 1/5th for testing. Training and validation data 
did not have patients that overlapped with the patients in the data held for testing.  
 
Figure 5.2.  Architecture of the simple fully connected neural network used to predict voxel-wise k1. 
5.2.4 GAN 
5.2.4.1 GAN – rationale. No matter how many voxels are used for training, if we have only a 
pool of 30 exams, and 22 patients, each voxel will come from one of 30 categories defined by the 
precise input functions that corresponded to that exam. This inspires data augmentation for the 
set of input functions to ensure the training data is better spread across the reasonable space of 
input functions. A GAN is a reasonable choice for this generative task. This approach trains both 
a generator and a discriminator, who act as adversaries to one another. The generator seeks to 
generate artificial input functions that are in the space of real input functions. The discriminator 
attempts to discriminate between the real examples and those generated artificially. Eventually, 
the generated examples should be essentially indistinguishable from examples drawn from the 
true dataset. GANs have been applied in a number of circumstances, involving both temporal 
biological signal49 and  medical image 50,51 generation, including generation for data 
augmentation 52. Here we use a generative adversarial neural network to generate arterial and 
portal venous input functions for gadoxetic acid dynamics in the liver.  
 
5.2.4.2 GAN design and implementation.  The GAN consisted of a simple network for 
conversion of a random vector (length 20) into outputs corresponding to arterial (Ca) and portal 
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venous (Cpv) input functions (two vectors of length 100) along with an indicator of the sampling 
period T. The network architecture can be seen in Figure 5.3. 
The generated input functions are then used as to create tissue concentration curves (Ct) using the 
DITC model.  
 
Figure 5.3. The design of the GAN used for generation of Ca and Cpv curves. Parenthetical values represent the dropout rate for 
dropout layers, the gradient of the leaky Relu, and the number of size for all other layers. 
5.2.4.3 NN augmentation from GAN data.  Training using the GAN generated data serves a dual 
purpose – firstly it acts as a confirmation that the GAN generated data is actually representative 
of the real Ca and Cpv curves, secondly, it could improve prediction accuracy with comparatively 
minimal chance of overfitting, based on the increased variability in Ca and Cpv for the training 
data. This dataset then has ground truth DITC defined uptake rates with input functions 
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replicating the variation observed empirically. This data can be used to augment the real data in 
training neural models to determine uptake from restricted datasets. 
In order to train a network to generated Ca and Cpv curves from a random vector, training data 
was created by first generating 1 million random Ca and Cpv pairs with corresponding T. This 
was performed for 5 holdout groups of patients corresponding to the training holdout groups 
described in 5.2.3 to ensure the learned sets were not influenced by testing patients’ own data. 
For each of these sets of Ca and Cpv curves, k1 and vdis values were randomly selected from the 
relevant patient set (excluding holdout patients), while ka, kpv, Ta and Tpv were randomly selected 
from roughly physiologically reasonable ranges (see Table 5.1). Ct curves were then generated 
from the DITC model using the GAN generated Ca and Cpv functions along with the random 
parameters described in table 5.1 as inputs to the model. Finally, gaussian distributed noise was 
added such that the measured SNR would be 40 dB. 
Table 5.1. The values used for the generation of training data using the dual-input, two-compartment model. Note that U(a,b) is 
the uniform distribution from a to b, and N(µ,σ2) is the normal distribution about µ with standard deviation σ. In this case the 
normal distribution was truncated to remove results outside the range [0,1]. 
Parameter Distribution  
k1,vdis Randomly drawn from patient 
set  
mL/100mL/min, 
mL/mL 
kpvp+ kap U(50,300) mL/100mL/min 
kpvp N(0.75, (1/16)
2)(kpvp+ kap),  mL/100mL/min 
   
5.2.4.4 LSITC optimization from GAN data.  Finally, consideration was given to minimize the 
error in LSITC analysis. The two obvious “tunable” parameters are t0 and sampling time. The 
parameter t0 refers to the first time point considered to satisfy the conditions of the LSITC model 
and thus used as the first point in the linear fit of the model. This is currently selected through a 
maximization of linearity as calculated by the ratio of singular values 22. Determination of the 
sampling times is more complex, particularly if we implement irregular sampling as in LTR 
collection. This chapter uses the GAN simulated data to optimize t0 and the sampling times, 
discretized in 30 second increments, for the LSITC analysis. Optimization is performed using a 
genetic algorithm to search for t0 and sampling times. Breaking the signal into 30 seconds 
intervals increased the tractability of the problem for this discrete genetic algorithm. This 
resulted in each of the sampling points being chosen from 32 intervals of 30 seconds in the 16 
minute datasets, where the first and last points are required. This was performed for 1 to 10 
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additional points, where the choice of points was optimized to minimize MSE error in a set of 
GAN based DITC generated synthetic voxels. 
5.2.5 1D CNN 
In addition to the application of a simple linear network to LTR data as discussed in 5.2.3, a 
reliable estimate of uptake rate from a 10 minute scan would be a meaningful improvement for 
patients and clinicians. With the expansion of the dataset complexity from LTR to HTR data it is 
likely that additional network capacity will be rewarded with superior results.   Since the 
elements of the temporal sequence are highly correlated, a 1D convolutional neural network 
(CNN) approach is a logical extension that allows for expanded capacity without a needless 
ballooning of parameters.  
 
 
Figure 5.4. The design of the 1D CNN applied to HTR data. Convolutional layer 1 contains 8  filters with width 9, convolutional 
layer 2 contains 16 filters with width 5, and the fully connected contains 10 neurons). 
To this end, a 1D CNN with 4 hidden layers (8  filters with width 9, 16 filters with width 5, A 
dropout layer, and a fully connected layer with 10 neurons) was trained on voxel-wise HTR data 
to predict k1 (Figure 5.4). Training data was drawn from a similar pool as for LTR data in 5.2.3, 
but all training data was concatenated to 10 minutes. Final testing was likewise only performed 
for data concatenated to 10 minutes after the beginning of the arterial peak.  
5.2.6 Error metric for evaluation of analysis methods and acquisition paradigms 
For each method and dataset used to estimate k1, the error was measured as NRMSE with the 
results of least squares fitting of the LSITC model for the full length (16-21 min) HTR dataset as 
the reference. NRMSE is defined here as RMSE normalized on an exam by exam basis by the 
interquartile range of the reference values as:  
𝑁𝑅𝑀𝑆𝐸 =
𝑅𝑀𝑆𝐸
𝑖𝑛𝑡𝑒𝑟𝑞𝑢𝑎𝑟𝑡𝑖𝑙𝑒 𝑟𝑎𝑛𝑔𝑒
      (5.1) 
Mean NRMSE is merely the mean across all exams analyzed.  
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The reference values were restricted to the values with a relative uncertainty below the 75th 
percentile. This minimizes the likelihood of performing the comparison with outliers and 
artifacts, such as those seen on some edges, but will also tend to decrease the denominator in the 
NRMSE calculation. 
Relative uncertainty was measured as the expected standard deviation in k1 estimation for the fit 
in a given voxel divided by the predicted k1 for that voxel.  Here the variance in k1 is estimated 
by the Taylor expansion of the variation of K1/vdis (where K1 is the slope in equation 2.10) as: 
𝑣𝑎𝑟(𝑘1) = 𝑣𝑎𝑟 (
𝐾1
𝑣𝑑𝑖𝑠
) ≈ µ𝐾1
2/µ𝑣𝑑𝑖𝑠
2(
𝜎𝐾1
2
µ𝐾12
−
2𝐶𝑜𝑣(𝐾1,𝑣𝑑𝑖𝑠)
µ𝐾1µ𝑣𝑑𝑖𝑠
+
𝜎𝑣𝑑𝑖𝑠
2
µ𝑣𝑑𝑖𝑠
2)   (5.2) 
where  
𝜎𝐾1 = √
∑ (?̂?𝑖−𝑦𝑖)
2
𝑖: 𝑥𝑖=𝑥0
(𝑛−2)∑ (𝑥𝑖−?̅?𝑖)
2
𝑖: 𝑥𝑖=𝑥0
      (5.3) 
𝜎𝑣𝑑𝑖𝑠 = √(
1
𝑛
)∑ (𝑥𝑖)2𝑖: 𝑥𝑖=𝑥0       (5.4) 
Where 𝜎𝑎 and µ𝑎 are the respective standard deviations and means of any given measure a. x and 
y are defined in equation (2.10). 
All results from five methods and datasets were compared to the k1 estimated by fitting the 
LSITC model for HTR data at maximum length (at least 16 minutes and no more than 21 
minutes), which are summarized in Table 5.2. 
Table 5.2. The abbreviations used for each method and data pairing evaluated along with a description of the relevant method 
and data. 
Method/Data Abbreviation Method Description Input Data Description 
LSITC-HTR Fitting of LSITC model with t0 
chosen to maximize linearity 
HTR data, with the data length 
truncated to a maximum length of 4 
to 16 minutes 
LSITC-LTR Fitting of LSITC model with t0=75 
seconds 
LTR data, with the data length 
truncated to a maximum length of 4 
to 16 minutes. The initial points 
spaced at 25 second intervals. 
NN-LTR Application of the NN model 
trained by k1 resulting from LSITC-
HTR for full HTR datasets 
LTR data, with the data length 
truncated to a maximum length of 4 
to 16 minutes. The initial points 
spaced at 25 second intervals. 
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Augmented NN-LTR Application of the NN model 
trained by DITC based data using 
input functions generated by GAN. 
LTR data, with the data length 
truncated to a maximum length of 4 
to 16 minutes. The initial points 
spaced at 25 second intervals. 
OPT LSITC-LTR Fitting of LSITC model with 
algorithmically chosen sampling 
times and t0 
8 points selected algorithmically to 
minimize error in augmented 
dataset. Truncated to a maximum 
length of 8 to 16 minutes. 
LSITC HTR t0 = OPT Fitting of  LSITC model with HTR 
data but t0 set to the optimum found 
in OPT LSITC-LTR 
HTR data, with the data length 
truncated to a maximum length of 4 
to 16 minutes 
5.3 Results 
5.3.1 Fitting of LSITC model 
As expected, directly fitting the LSITC model to HTR data yielded more accurate k1 values than 
fitting to LTR data. For both datasets the errors grew rapidly with a decrease in the acquisition 
length of the data (see Figure 5.5). At full acquisition length (16 minutes), LSTIC-HTR and 
LSITC-LTR resulted in an average NRMSE across exams of 0.60 (SD 0.38) and 1.77 (0.99), 
respectively. At an acquisition length of 10 min the average NRMSE increased to 2.59 (1.34) and 
3.09 (1.54) for HTR and LTR datasets, respectively, as seen in Table 5.3. A visual comparison at 
10 minutes can be seen in Figure 5.6. 
  58 
 
Figure 5.5. Errors of estimated k1 values with varied acquisition lengths for the tested methods. 
 
Figure 5.6. The k1 maps created using the HTR and LTR data truncated at 10 min both from directly fitting the LSITC model 
(second and third columns) and from the NN and GAN augmented NN models (fourth and fifth columns respectfully). The first 
column displays the reference k1 images by fitting the LSITC model to full length HTR data acquired over approximately 20 min.  
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5.3.2 NN model 
The NN model yielded significantly reduced error rates in k1 estimation over direct fitting of the 
LSITC model to the LTR data at all tested acquisition lengths (4-20 min). When the acquisition 
length was less than 14 min, the NN model applied to the LTR data resulted in the errors less 
than directly fitting of the LSITC model to the HTR data. This difference became significant for 
acquisitions of 10 minutes or less.  The errors yielded by the NN model increased slowly with 
the acquisition length reduction, suggesting the NN model was resilient to data length.  In 
contrast, direct fitting of the LSITC model yielded quickly increased errors with the data length 
reduction, regardless of the temporal resolution of the data (Figure 5.5).  
5.3.3 GAN augmented NN model 
On visual inspection randomly selected curves generated by the trained GAN seemed to replicate 
the basic features of the measured curves without being direct copies of individual examples. For 
randomly selected GAN generated Ca curves, the nearest normalized neighbor was found from 
the measured set of input curves. Three examples are shown in Figure 5.7. In each column the 
top plot is a randomly selected generated Ca and Cpv pair, and the bottom plot is the real Ca and 
Cpv pair whose normalized Ca curve is the nearest neighbor to the generated Ca curve based on a 
sum of squares difference. The comparisons did not show evidence of direct replication of the 
specifics of particular measured curves. 
In addition to visual inspection, the distribution created by the GAN was assessed by producing 
histograms approximating the probability distribution of the pairwise Euclidean differences 
between examples within the measured data, as well as the pairwise differences in data generated 
by each GAN. Figure 5.8 displays these distributions of pairwise differences for each GAN, 
superimposed over the distribution of pairwise differences for the measured data. The difference 
between the mean distance for each GAN and the measured data is shown, along with the earth-
movers-distance (EMD) to better represent the differences between distributions. In all cases the 
distribution of differences in GAN data visually mirrors that of the full dataset, with the 
smoothing we would expect from a larger number of samples from a similar dataset. 
Augmentation with GAN generated data gave mixed results. Training on only synthetic data 
resulted in improvement over prediction error from training only on real data (Figure 5.5). With 
a statistically significant improvement in error over LSITC HTR for all datasets of length 12 
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minutes or less, and no significant drop in error up to 15 minutes. However, combining the real 
data with additional synthetic data did not meaningfully improve the prediction error. The results 
of augmented NN model trained by synthetic data only are shown in Figure 5.5 and Table 5.3 
(Augmented NN-LTR). 
 
Figure 5.7.  Examples of generated (top row) and nearest neighbors from the measured (bottom row) Ca and Cpv curve pairs. 
Nearest neighbors were calculated based on the sum of squared differences in Ca alone. 
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Figure 5.8.  For each of the 5 GANs used, the probability distributions for L2 norm of the distance between randomly selected Ca 
and Cpv curves for GAN generated data is shown in red. The probabilities for the measured data are shown in blue as reference. 
5.3.4 Optimization of time points for the LSITC model fitting 
When selecting the optimum sampling points for the LSITC model fitting, as additional points 
were selectively added to the set, optimization yielded a t0 of 3 minutes in every case, without 
any sampling point prior to t0. The sampling times chosen tended to group just after t0, and near 
the end of the dataset. The error leveled off near 8 points in the simulated data, as seen in Figure 
5.9. As a result, 8 points were used when testing this approach, apart from the pre-contrast and 
final points. 
Implementation of the GAN data for LSITC optimization (OPT-LSITC LTR) yielded errors 
significantly lower than direct fitting of the LSITC model to HTR data with acquisition lengths 
of 12 min or less, and lower than NN models for data lengths greater than 10 minutes (Figure 
5.5).  This suggests that optimization of the time of data point acquisition could improve the 
performance of the LSITC model, but the NN model with non-optimized data still could perform 
better at a short acquisition length. 
A further test of the optimal t0 (3 min) was performed with full HTR data.  As seen in Figure 5.5, 
the LSITC model fitting to HTR with a dynamic t0 (LSITC-HTR) and an optimal t0  (LSITC-
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HTR t0=OPT) yielded similar results, but worse results than the LSITC model fitting to the 
optimal 8-point LTR data (OPT LSITC LTR), indicating that the robustness of performance of 
the optimized LSITC is not merely due to the choice of t0 but due to the particular set of points 
selected. 
 
Figure 5.9. The errors in simulated and real data as a function of the number of optimum sampling points using a procedure 
derived from the genetic algorithm.  Note that error in the data leveled off after 8 points. 
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Table 5.3. Error rates (NRMSE) for each method as function of data length. Statistically significant improvements in NRMSE 
over LSITC HTR are indicated by an asterisk (*). Statistically significant increases in error are indicated by a negated asterisk. 
Significance was estimated based on a two sample t-test with a significance level of 0.05, except for the Max row, where a single 
sample t-test was used. 
Series 
Duration 
(min) 
NRMSE - mean (standard deviation) 
LSITC HTR LSITC LTR NN LTR 
Augmented 
NN LTR  
OPT LSITC 
LTR 
LSITC HTR 
t0 = OPT 
4 7.17 (4.39) 7.21 (3.93) 2.44 (2.06)* 2.15 (1.78)*  14.64 (9.44) -* 
5 5.86 (3.47) 6.21 (3.24) 2.21 (1.79)* 1.91 (1.43)*  7.78 (4.58) 
6 4.68 (2.72) 5.01 (2.95) 2.04 (1.52)* 1.82 (1.16)*  5.27 (3.18) 
8 3.27 (1.79) 4.02 (2.35) 1.71 (1.15)* 1.52 (0.85)* 1.97 (1.39)* 3.05 (1.78) 
10 2.59 (1.34) 3.09 (1.54) 1.54 (0.93)* 1.41 (0.75)* 1.38 (0.72)* 2.23 (1.17) 
12 1.81 (1.08) 2.57 (1.39) -* 1.44 (0.79) 1.32 (0.67)* 1.07 (0.57)* 1.60 (0.99) 
14 1.31 (1.01) 2.05 (1.27) -* 1.32 (0.71) 1.24 (0.62) 0.90 (0.53) 1.14 (0.90) 
15 0.92 (0.61) 1.79 (1.07) -* 1.28 (0.68)-* 1.24 (0.63)  0.86 (0.62) 
15.5 0.78 (0.52) 1.80 (1.02) -* 1.25 (0.64) -* 1.20 (0.58) -*  0.76 (0.54) 
16 0.60 (0.38) 1.77 (0.99) -* 1.22 (0.69) -* 1.21 (0.66) -* 0.77 (0.42) 0.68 (0.50) 
Max 0.00 (0.00) 1.39 (0.80) -* 1.14 (0.58) -* 1.06 (0.56) -* 0.72 (0.33) -* 0.42 (0.26) -* 
 
5.3.5 1D CNN 
The error rate in terms of NRMSE relative to the full length LSITC-HTR was comparable to the 
error rate from merely altering t0 for full length data as in 5.3.4, giving an NRMSE of 0.53 with a 
standard deviation of 0.26. This also compares favorably with the error rate of LSTIC-HTR after 
truncation to 16 minutes. Visually the maps seemed to replicate physiological patterns in the 
reference images with a reduction of outliers and edge effects (See Figure 5.10). The correlation 
with the reference was R = 0.93. 
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Figure 5.10. Example maps of uptake rate based on (top to bottom in each block) LSITC and DSITC models for full length HTR 
data, and the CNN for only 10 minutes of data. The colormap depicts the value from 0 to 25 mL/100mL/min. 
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5.4 Discussion 
In this chapter, we developed NN models for estimation of k1 and compared the results of the 
NN models to those from direct fitting of the LSITC model for various acquisition lengths and 
temporal resolutions of Gadoxetic acid enhanced dynamic MRI of the liver.  Overall, the NN 
models are more resilient to the acquisition length reduction.  The augmented input functions 
using GAN can further improve the performance of the NN models. For direct fitting of the 
LSITC model, ten optimized time points in the Gadoxetic acid enhanced dynamic data can 
significantly out-perform the HTR data (5-10 sec per volume) for acquisition lengths of 12 
minutes or less, and the NN method for acquisition length not shorter than 8 minutes.  This work 
suggests that the NN approach can be used to enhance the performance of k1 estimation and 
optimize the data acquisition. 
A key element of modeling liver pharmacokinetics is obtaining arterial and portal venous input 
functions. These input functions have been estimated using combinations of exponentials and 
other simplifications, but this involves either profound simplification or the development of 
models of increased complexity without a guarantee of successfully capturing the relevant 
features of the input functions. Use of measured input functions has notable advantages in 
capturing the true empirical characteristics of these input functions. However, when employing 
data driven methods this will practically limit the researcher to a relatively small number of 
example cases. When machine learning methods are applied to millions of voxels but the guiding 
input functions consist of a few dozen examples, we may fear overlearning these limited 
underlying examples, rather than a more useful learning of the underlying relationships between 
our relevant parameters and input functions in general. Addition of noise or variation in sampling 
time may make this underlying granularity less starkly memorable. However, a more ideal 
solution would be the construction of arbitrary or random input functions from the feature space 
the input functions inhabit. A promising means for this generative task is a generative adversarial 
neural network.  
One difficulty in generative networks, where the network is not cyclic (generating corresponding 
examples in another space rather than arbitrary or random examples in the desired space) is 
assessment of the quality of the generative model. One approach is the usage of these examples 
as augmentation data for a relevant learning task. If the augmentation helps, it is more reasonable 
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that the generative model is representing the variation in the underlying set appropriately, or at 
least in a way that helps the trained network to better understand the relevant relationships. Here 
we used a generative adversarial neural network to generate arterial and portal venous input 
functions for gadoxetic acid kinetics in the liver.  
The augmented NN that was trained only on GAN generated data resulted in superior results as 
compared to the NN trained using any fraction of the measured data with HTR-LSITC as the 
reference. There are various possible causes of the decrease in performance with the addition of 
real data. It is likely that the very few input functions were not useful in further generalizing the 
solution over the training from the GAN and DITC generated data. It may also have skewed the 
solution towards those measured input functions. It should be noted that since the GAN itself is 
trained from measured data, the generated examples will include characteristics caused by 
sampling noise, movement and other variations in the data. Because of this the input to the DITC 
model generated from this GAN has variation that would not be expected in the underlying input 
functions in reality.  
In addition to the already mentioned benefits, the GAN derived data and DITC model defined 
reference values allowed the simulated dataset to be used to evaluate independent models 
relative to the DITC model. This allowed us to use references of not only our best estimate 
(whether DITC or LSITC) to complete (16+ min) real datasets, but also to the ground truth 
inputs to the DITC model without fitting error in the reference k1 values. This helps quantify 
possible error in these estimates and gives a parallel reference measure for restricted methods. 
This is of particular interest when attempting to assess optimum, or at least improved, acquisition 
times for the image volumes used to estimate k1. Use of these model defined input parameters 
made this optimization less susceptible to a mere reproduction of the linear fit of the LSITC 
model (along with any limitations or errors in this method), and helped to assess the best timing 
(giving the variability observed in the input functions) to acquire points for LSITC without bias 
to the timing used in the measured reference set. 
The optimal sampling points for OPT-LSITC LTR essentially followed the expected weights for 
a linear regression, in that points near the end were preferred, with successive trials adding points 
closer to the center as those at the ends were already included. The selection of t0 is perhaps 
more salient, indicating that the addition of a point near the 3 min mark would aid LSITC 
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accuracy when applied to LTR data. This time roughly corresponds to the equilibrium phase 53, 
which would logically initiate the portion of the data where the assumptions of the LSITC model 
hold true. This approach resulted in lower error than even LSITC applied to HTR data from 15.5 
to 8 min, for the real dataset, even though the reference was used HTR data with a variable t0. 
This also casts doubt on the use of 75 seconds as t0 in LTR data. If 3 minutes is the location of 
the equilibrium phase, then voxel-wise LSITC analysis of most LTR data has only 2 data points 
to work with, since none of the arterial or portal venous phase points will fall after that point. 
Without an overdetermined fit the error rates will likely be large, and concurrent error 
quantification will rely on assumptions regarding the similarity of nearby points. However, the 
selection of t0 was not the primary factor in the improvement over other LSITC methods. This is 
apparent from the small difference between LSITC-HTR and LSITC-HTR where t0 = OPT. This 
indicates that the specific selection of points was helpful in improving the fit. It is possible that 
some of the improvement came from selecting no points prior to t0. This does not change which 
points are fit, but does change the x and y vectors since the integral of Ca will differ in equation 
2.10. It may be that the discrepancy of Ca from Cpv increases the error in datasets that include 
pre-t0 sampling points. 
Regardless of the method used the error was greater for shorter datasets. Data length was 
especially significant for LSITC analysis, for both LTR and HTR data. With a fixed best t0 and 
careful choice of sampling points this was reduced somewhat, perhaps making acquisitions as 
short as 12 minutes practical. Below this level the NN methods worked best, showing relatively 
little change in error with data length in time. This indicates that the underlying information is 
sufficient for a comparatively accurate prediction even with relatively short collection time used 
by the NN. However, the results did not outperform LSITC-HTR for long datasets. In each of 
these cases it is important not to interpret the error in absolute terms, particularly near the 
maximum length. Remember that the error measures will be impacted by error in the results of 
LSITC applied to HTR. 
Use of the LSITC model as the reference allowed rapid analysis and comparison with regard to 
k1, even for LTR data. In a previous study, k1 values estimated from the LSITC and DITC have 
been compared and the results are very similar22.  However, this model does omit parameters 
present in the DITC model, notably ka and kpv. Previous studies have correlated portal venous 
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perfusion to liver function54 and arterial perfusion to tumor presence20. Theoretically, 
simultaneous quantification of k1, ka and kpv from a single dynamic MRI acquisition using the 
DITC is advantageous.  Practically, there are some limitations.  The FDA approved standard 
dose of Gadoxetic acid only contains a quarter of the Gadolinium in a standard dose of Gd-
DTPA or Multihance.  This results in a weak contrast enhancement and a low signal-to-noise 
ratio in the arterial phase signals, thereby challenging reliable quantification of arterial perfusion.   
Therefore, in practice, if tumor diagnosis and assessment are the primary interest, Gd-DTPA or 
Multihance is used.  If liver function measurement is the primary interest, Gadoxetic acid is used.  
If both tumor assessment and liver function are of interest, a trade-off has to be made.  Compared 
to the DITC and LSITC models, the Tofts model only considers the contrast transport between 
the intra-vascular and the extra-cellular space, which can only be applied for an extra-cellular 
contrast agent, but not an intra-cellular agent, like Gadoxetic acid.  
5.5 Conclusions 
Data length is significant for LSITC analysis as applied to DCE data for standard temporal 
sampling. With a fixed best t0 and careful choice of sampling points this can be reduced 
somewhat, particularly for acquisitions at least 12 minutes in length. Below this level the NN 
worked best, indicating that NN methods may be helpful in improving the robustness of uptake 
analysis in temporally short datasets. Combination of a GAN with DITC model created data 
contributed to the training of the NN, indicating the variation in input functions was being 
appropriately represented. Further work should assess the impact on functional avoidance 
therapy dependent on the means used to create functional maps. 
  69 
CHAPTER 6  
Conclusions, Summary, and Extensions 
 
This work has introduced a method, LSITC, for the robust quantification of voxel-wise liver 
function using DGAE MRI. This method was validated through various means in chapters 2 and 
3, with voxel-wise validation most pronounced in chapter 2 and global validation most 
pronounced in chapter 3. LSITC can be used in the place of DITC to give more robust and rapid 
estimates of gadoxetic acid uptake rate. Furthermore, chapter 3 establishes this measure can be 
used to predict global function, based on comparisons with both ICGR and ALBI. The validation 
of uptake rate based measures simultaneously casts doubt on portal venous perfusion as an 
accurate and robust measure of liver function in some patient populations. In this instance the 
patient population had a very high prevalence of HCC and Cirrhosis, with ICGR and ALBI 
scores depicted many cases with profoundly compromised liver function. The inclusion of best 
fits between ALBI, ICGR and uptake derived measures also creates an initial conversion 
between these measures. In cases where guidelines, recommendations, and significant prior 
protocols rely on ALBI or ICGR this enables use of DGAE imaging alone to obtain the needed 
information and adhere to the desired protocol. Ideally, DGAE MRI is be able to simultaneously 
allow clinicians to 1) characterize intrahepatic lesions, 2) quantify total liver function, and 3) 
guide regional function based RT optimization.  
 
Chapter 4 explored the impact of using uptake maps as opposed to perfusion maps for functional 
avoidance RT planning. The results of these disparate means of determining function had a real 
impact on treatment planning, though, perhaps surprisingly, it may not always be as pronounced 
as we would suppose. This is partially because there are already intense constraints on the 
planned dose distribution. After ensuring the organ at risk constraints are met, and the target dose 
is being delivered, much freedom has already been lost, such that while it remains possible to 
alter the dose delivered to the highly functional regions, the results will be strongly impacted by 
the position of the functional regions relative to the target. Furthermore, despite relatively weak 
ranked correlations between k1 and k2 (or kpv), there are many ways for the spatial distributions 
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of relatively high k1 and k2 regions to motivate a similar ultimate dose distribution. Both plans 
succeed in somewhat reducing dose to the specified regions. It was only in individual cases 
where the mismatch is most extreme that the differences were more substantial. In cases like this 
in particular we would expect treatment planning optimization to differ significantly, failing to 
reap the full benefits of functional avoidance treatment planning if we use perfusion as a 
surrogate for function. We might also expect additional gains for more sophisticated functional 
avoidance plans that account for expected functional loss based on the predicted dose response of 
the tissue. With increasingly granular and finely tuned optimization, we should expect the 
detailed differences between methods of function to increasingly matter to the function 
ultimately retained. An additional relevant step towards maximizing function guided RT 
effectiveness and minimizing RT risk is therefore a detailed statistical model of the functional 
response of gadoxetic uptake rate as a function of radiation dose. An analysis of pre and post RT 
uptake maps for the enacted RT plan would enable development of this model.  
 
Chapter 5 has both probed the error rates of the LSITC model for very limited cases, and 
investigated the application of machine learning approaches to these limited datasets.  
The examination of error across various analysis methods and suboptimal datasets in chapter 5 
provides some insight into possible extensions. LTR data can be used to get more accurate 
assessments than direct application of LSITC to conventional LTR data would allow. This is 
easily seen in the relative stability of the error rate when using a NN. The application of a CNN 
based approach to 10 minutes of HTR data is a simple inclusion in the chapter with potentially 
large clinical implications. A reliable estimate of uptake rate from a 10 minute scan would be a 
meaningful improvement for patients and clinicians. However, the application of machine 
learning to DGAE scans in Chapter 5 only scratches the surface of the potential in this area. An 
additional architecture of interest for this problem is a long short-term memory (LSTM) network 
which would better enable the interaction of relevant information across temporally distant 
regions of the signal. This architecture has been applied to the determination of pharmacokinetic 
parameters of Gadobenic acid perfusion in head and neck scans55. 
 
There are additional implications on data acquisition as well. The reduction of total acquisition 
length achievable via the CNN approach is attractive, but there are also indications that the utility 
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of the timeseries is not equally spread across the timespan of the scan. This is a very intuitive 
result based on the structure of the characteristic concentration curves, but finds validation in the 
relative benefit of the “optimized” placement of points seen for the “OPT LSITC LTR” 
approach. Since the fundamental relationship governing the uptake rate can be viewed as a linear 
problem through the LSITC model, it is expected that data from the very beginning of the, and as 
late as possible in the hepatobiliary phase would be most beneficial in acquiring a robust fit. This 
model based assessment gives one answer for the characterization of which portions of the data 
range are most important. This could also be assessed without an assumed static model. A neural 
network with attention mechanisms  would not only provide an interesting solution to the 
problem, but examination of the relative attention in different areas of the timeseries could also 
give an indication of the temporal location of the information most statistically salient in 
determining the uptake. 
 
This work has real and immediate clinical applications, where robust measures of gadoxetic acid 
uptake rate allows for a simplification of overall clinical workflow through a reduction in the 
number of tests needed,  while simultaneously allowing for more advanced tailoring of radiation 
therapy plans and progression.
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APPENDIX A 
Formulation of dual-input two-compartment equations 
The change in the total amount of contrast in the distribution volume in a voxel is: 
Vdis
dCdis(t)
dt
 = FapCap(t-τa)+FpvpCpvp(t-τpv)-(Fap+Fpvp+K1)Cdis(t)   (1A) 
 
where Fap, and Fpvp are the total amounts of arterial blood plasma flow and portal vein blood 
plasma flow in the distribution space in the voxel, respectively, and K1 is the amount of contrast 
taken up by cells per second in the voxel. Fap, Fpvp and K1 have a unit of vol/s. 
 
The change in the total amount of agent in the intracellular volume in the voxel is: 
 
Vi
dCi(t)
dt
 = K1Cdis(t)     (2A) 
 
 
Where Vi is the intracellular volume in the voxel. 
Equation (1A) can be re-written as: 
Vdis
dCdis(t)
dt
 = FapCap(t-τa)+FpvpCpvp(t-τpv)- [
Fap+Fpvp+K1
Vdis
]VdisCdis(t) 
                                   = FaCa(t-τa)+FpvCpv(t-τpv)-(k2+k1)VdisCdis(t)                              (3A) 
Where k2 = (Fap+Fpvp)/Vdis, and k1 = (K1)/Vdis, both of which are rates in units of inverse seconds. 
Fa and Fpv are the total amounts of arterial blood and portal vein blood flow, respectively.  Here, 
we use the relationship: FtCt = FpCp+FredCred, which means the total amount of blood flow times 
total concentration of agent in blood is equal to the amount of blood plasma flow times the 
concentration of agent in plasma plus the amount of blood red cell flow times the concentration 
of agent in red cells.  Since Cred is zero, FtCt = FpCp (agent does not enter red cells). Also, we 
cannot measure the concentration of agent in plasma, but can measure the concentration of agent 
in the total blood.   
  73 
Using hematocrit Hct, we have k2 = ((1-Hct)(Fa+Fpv))/Vdis. 
The solution of (3A) is: 
VdisCdis(t)=∫ [FaCa(τ-τa)+FpvCpv(τ-τpv)]
t
0
𝑒-(t-τ)(k2+k1)dτ    (4A) 
The solution of (2A) is: 
ViCi(t) = K1 ∫ Cdis
t
0
(τ)dτ     (5A) 
The total account of contrast in the voxel is:  
VtCt(t) = VdisCdis+ViCi+V
'
eC
'
e = VdisCdis+ViCi         (6A) 
Where C'e is zero. 
The final solution of the total amount of agent in a voxel or volume of interest is: 
VtCt(t) = ∫ [FaCa(τ-τa)+FpvCpv(τ-τpv)]
t
0
e-(t-τ)k2dτ+ K1 ∫ Cdis
t
0
(τ)dτ      (7A) 
 
The unknown parameters in (7A) are Fa, Fpv, k2 (or Vdis), K1, and τa and τp. 
Conventionally, we present blood flow in density so that after quantification of Fa, Fpv and K1 
per voxel or per volume of interest we need to calculate Fa (Fpv or K1)/Vdis.   
We can re-write the solution of (4A), and (5A) as: 
VdisCdis(t ) =∫[FaCa(τ-τa)+FpvCpv(τ-τpv)]
t
0
e-(t-τ)k2e-(t-τ)k1dτ  
= Vdis ∫ [kaCa(τ-τa)+kpvCpv(τ-τpv)]
t
0
e-(t-τ)k2e-(t-τ)k1dτ   (8A) 
 
ViCi(t) = K1 ∫ Cdis
t
0
(τ)dτ = k1 ∫ VdisCdis(τ)
t
0
dτ     (9A) 
 
Therefore, we can combine (8A) and (9A) to re-write (6A) as (2.1) and (2.2): 
 
VtCt(t)
⏞    
Agent in Tissue
= vdisCdis(t)
⏞    
Exctracellular Agent
+ k1 ∫ vdisCdis(τ)dτ
t
0
⏞          
Intracellular Agent
     (2.1) 
 
VdisCdis(t)=Vdis ∫ (kaCa(τ-τa)+kpvCpv(τ-τpv))
t
0
e-(t-τ)(k2+k1)dτ   (2.2)
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APPENDIX B 
Solution to three parameter linearization 
We can recast equation (2.8) in the form y = ax1+bx2+cx3, where 
 𝑦 = (1 − 𝐻𝑐𝑡)𝐶𝑡(𝑡), 
 ?⃗? = (𝑥1, 𝑥2, 𝑥3) = (𝐶𝑎(𝑡), ∫ 𝐶𝑎(𝜏)
𝑡
0
𝑑𝜏,
𝑑𝐶𝑎(𝑡)
𝑑𝑡
), 
𝑎 = 𝑣𝑑𝑖𝑠
𝑘2
𝑘1+𝑘2
(1 −
𝑘1
𝑘1+𝑘2
), 
𝑏 = 𝑣𝑑𝑖𝑠
𝑘1𝑘2
𝑘1+𝑘2
, 
𝑐 = −𝑣𝑑𝑖𝑠
𝑘2
(𝑘1+𝑘2)2
. 
Through algebraic manipulation of the final three terms we can then solve for k1, k2, and vdis in 
terms of the coefficients of this model. 
 
𝑘2 = − 
𝑎
𝑐
       (1B) 
𝑘1 = −
𝑘2
2
+√
𝑘2
2
4
−
𝑏
𝑐
      (2B) 
𝑣𝑑𝑖𝑠 = 
𝑏(𝑘1+𝑘2)
𝑘1𝑘2
       (3B) 
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